Growth promoting peptides, and uses thereof

Abstract

A natural peptide comprising a cellular growth promoting fragment of a protein selected from SEQ ID NOs: 1 to 13, and a composition comprising a plurality of growth promoting peptides, is described. Also disclosed is the use of the peptides and compositions in prevention of ageing of human skin, treatment of diseases or conditions characterised by damaged epithelial cells or tissue such as colon cancer and peripheral inflammatory disorders, and wound treatment. Specific pea and rice protein derived peptides are described in SEQ ID NOs: 15 to 505, and 546 to 704.

Claims

1. A peptide comprising the amino acid sequence of SEQ ID NO: 245, wherein the peptide is up to 50 amino acids in length.

2. The peptide of claim 1, wherein the peptide is growth promoting.

3. The peptide of claim 1, wherein the peptide consists of SEQ ID NO: 245.

4. The peptide of claim 1, wherein the peptide is a modified peptide.

5. The peptide of claim 1, wherein the peptide is further modified by incorporation of a protecting group, incorporation of unnatural amino acids imposing conformational constraint on the peptide.

6. A conjugate comprising a peptide of claim 1 coupled to a binding partner, wherein the binding partner is selected from the group consisting of polyethylene glycol (PEG), polyoxyethylene glycerol (POG), poly-lysine, poly-glutamic acid, poly-aspartic acid, a lipophilic moiety comprising a hydrocarbon chain of 4 to 30 carbon atoms, albumin, gelatin, fatty acid, polysaccharide, dextran, cell penetrating peptide, and antibody molecule.

7. A composition comprising the peptide of claim 1, the peptide of claim 3 or the conjugate of claim 6.

8. The composition according to claim 7, wherein the composition is in the form of a powder.

9. The composition according to claim 7, wherein the composition is formulated for topical application to the skin of a human.

10. The composition according to claim 7, wherein the composition is in the form of serum, gel, cream, lotion, emulsion or ointment.

11. The composition according to claim 7, wherein the composition further comprises a cosmetically or pharmaceutically acceptable excipient.

12. The composition according to claim 7, wherein the composition further comprises a cosmetically acceptable excipient selected from the group consisting of emollient, diluent, carrier, binder, lubricant, suspending agent, coating agent, preservative, stabilizer, dye, vehicle, solubilising agent, base, emulsifying agent, fragrance, humectant, and surfactant.

13. The composition according to claim 7, wherein the composition is a personal care composition, a pharmaceutical composition, a cosmetic composition, a food or beverage or a nutritional supplement.

14. A method of slowing ageing of human skin, wherein the method comprises topically administering to the skin of a human the peptide of claim 1, the peptide of claim 3, the conjugate of claim 6, or the composition of claim 7.

Description

BRIEF DESCRIPTION OF THE FIGURES

(1) FIGS. 1 to 100: Effect of synthetic peptides of the invention on proliferation of Human Dermal Fibroblasts (HDF).

(2) FIG. 101: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on elastin synthesis of Human Dermal Fibroblasts (HDF).

(3) FIG. 102: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on collagen synthesis of Human Dermal Fibroblasts (HDF).

(4) FIG. 103: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on elastin synthesis of Human Dermal Fibroblasts (HDF).

(5) FIG. 104: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on collagen synthesis of Human Dermal Fibroblasts (HDF).

(6) FIG. 105: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on elastin synthesis of Human Dermal Fibroblasts (HDF).

(7) FIG. 106: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on collagen synthesis of Human Dermal Fibroblasts (HDF).

(8) FIG. 107: Effect of synthetic peptide of the invention (SEQ ID NO: 284) on elastin synthesis of Human Dermal Fibroblasts (HDF).

(9) FIG. 108: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on elastin synthesis of Human Dermal Fibroblasts (HDF).

(10) FIG. 109: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on collagen synthesis of Human Dermal Fibroblasts (HDF).

(11) FIG. 110, shows the integrity controls and viability controls for the assay system.

(12) FIG. 111. % of elastin expression in superficial dermis compared to control (water or DMSO) for peptides P1, P2 and P3.

(13) * shows significant increases of elastin expression in superficial AND middle dermis.

(14) FIG. 112. % of elastin expression in middle dermis compared to control (water or DMSO) for peptides P1, P2 and P3.

(15) * shows significant increases of elastin expression in superficial AND middle dermis.

(16) FIG. 113. % of cell proliferation in the basal layer of epidermis compared to control (water or DMSO) for peptides P6 and P8, and peptide compositions P9 and P10

(17) * shows significant increases.

(18) FIG. 114. Histological analysis of the elastic fibers (+catechin, ×200).

(19) FIG. 115. Immunohistochemical evaluation of the mitotic index (Ki67, ×400).

DETAILED DESCRIPTION OF THE INVENTION

Example 1—Cell Proliferation Assay

(20) BrDu is incorporated into newly synthesised DNA strands of actively proliferating cells. Following partial denaturation of double stranded DNA, Brdu is detected immunochemically allowing the assessment of the population of cells which are synthesizing DNA.

(21) Human Dermal Fibroblasts (HDF—Sigma 10605a) were seeded in a 96 well plate at 10,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

(22) Following the initial 24 h incubation the cells were incubated with 5 μg/ml, 0.5 μg/ml or 0.05 μg/ml synthetic peptide for 24 h respectively.

(23) After 18 h incubation with synthetic peptides 20 μl BrDu reagent was added to each well.

(24) At 24 h incubation the cell were fixed and the amount of 2-DG6P was measured using the BrdU Cell Proliferation Assay, all steps were carried out according to the manufacturer's instructions.

(25) Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates greatER incorporation of BrDu and increase cell proliferation.

(26) The results are shown in FIGS. 1-100 and Table 1 below.

(27) TABLE-US-00004 TABLE 1 INCREASE INCREASE FIG. SEQ ID IN PROLIFERA- FIG. SEQ ID IN PROLIFERA- NO NO: TION NO NO: TION 1 121 48% 29 98 49% 2 105 40% 30 454 38% 3 249 30% 31 85 35% 4 226 30% 32 453 25% 5 84 20% 33 158 21% 6 330 18% 34 464 18% 7 181 33% 35 73 16% 8 83 32% 36 359 15% 9 247 28% 37 124 15% 10 97 26% 38 112 15% 11 74 29% 39 733 12 40 728 13 168 41 727 14 151 42 730 15 470 119%  43 731 16 257 118%  44 148 17 256 117%  45 343 18 457 114%  46 345 19 499 113%  47 484 20 253 112%  48 729 21 222 110%  49 456 22 272 97% 50 494 23 252 111%  51 723 24 248 86% 52 722 25 472 77% 53 498 26 365 58% 54 475 13% 27 502 68% 55 718 28 496 51% 56 337  8% 57 500  6% 79 463 100%  58 717 80 465 96% 59 297 81 467 90% 60 340 82 461 85% 61 719 83 341 83% 62 726 84 468 82% 63 725 85 285 81% 64 724 86 496 81% 65 720 87 146 80% 66 721 88 478 76% 67 503 125%  89 452 76% 68 474 121%  90 495 68% 69 504 119%  91 403 51% 70 114 119%  92 455 47% 71 505 118%  93 270 47% 72 482 113%  94 501 43% 73 479 106%  95 473 41% 74 477 81% 96 39% 75 410 73% 97 471 38% 76 475 69% 98 460 38% 77 497 58% 99 93 26% 78 480 102%  100 462 15%

(28) FIG. 1 shows an increase in HGF cell proliferation of 48% when incubated with SEQ ID NO: 121.

(29) FIG. 2 shows an increase in HGF cell proliferation of 40% when incubated with SEQ ID NO: 105.

(30) FIG. 3 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID NO: 249.

(31) FIG. 4 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID NO: 226.

(32) FIG. 5 shows an increase in HGF cell proliferation of 20% when incubated with SEQ ID NO: 84.

(33) FIG. 6 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID NO: 330.

(34) FIG. 7 shows an increase in HGF cell proliferation of 33% when incubated with SEQ ID NO: 181.

(35) FIG. 8 shows an increase in HGF cell proliferation of 32% when incubated with SEQ ID NO: 83.

(36) FIG. 9 shows an increase in HGF cell proliferation of 28% when incubated with SEQ ID NO: 247.

(37) FIG. 10 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID NO: 97.

(38) FIG. 11 shows an increase in HGF cell proliferation of 29% when incubated with SEQ ID NO: 74.

(39) FIG. 15 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 470.

(40) FIG. 16 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID NO: 257.

(41) FIG. 17 shows an increase in HGF cell proliferation of 117% when incubated with SEQ ID NO: 256.

(42) FIG. 18 shows an increase in HGF cell proliferation of 114% when incubated with SEQ ID NO: 457.

(43) FIG. 19 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID NO: 499.

(44) FIG. 20 shows an increase in HGF cell proliferation of 112% when incubated with SEQ ID NO: 253.

(45) FIG. 21 shows an increase in HGF cell proliferation of 110% when incubated with SEQ ID NO: 222.

(46) FIG. 22 shows an increase in HGF cell proliferation of 97% when incubated with SEQ ID NO: 272.

(47) FIG. 23 shows an increase in HGF cell proliferation of 111% when incubated with SEQ ID NO: 252.

(48) FIG. 24 shows an increase in HGF cell proliferation of 86% when incubated with SEQ ID NO: 248.

(49) FIG. 25 shows an increase in HGF cell proliferation of 77% when incubated with SEQ ID NO: 472.

(50) FIG. 26 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID NO: 365.

(51) FIG. 27 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID NO: 502.

(52) FIG. 28 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID NO: 496.

(53) FIG. 29 shows an increase in HGF cell proliferation of 49% when incubated with SEQ ID NO: 98.

(54) FIG. 30 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 454.

(55) FIG. 31 shows an increase in HGF cell proliferation of 35% when incubated with SEQ ID NO: 85.

(56) FIG. 32 shows an increase in HGF cell proliferation of 25% when incubated with SEQ ID NO: 453.

(57) FIG. 33 shows an increase in HGF cell proliferation of 21% when incubated with SEQ ID NO: 158.

(58) FIG. 34 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID NO: 464.

(59) FIG. 35 shows an increase in HGF cell proliferation of 16% when incubated with SEQ ID NO: 73.

(60) FIG. 36 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 359.

(61) FIG. 37 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 124.

(62) FIG. 38 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 112.

(63) FIG. 54 shows an increase in HGF cell proliferation of 13% when incubated with SEQ ID NO: 475.

(64) FIG. 56 shows an increase in HGF cell proliferation of 8% when incubated with SEQ ID NO: 337.

(65) FIG. 57 shows an increase in HGF cell proliferation of 6% when incubated with SEQ ID NO: 500.

(66) FIG. 67 shows an increase in HGF cell proliferation of 125% when incubated with SEQ ID NO: 503.

(67) FIG. 68 shows an increase in HGF cell proliferation of 121% when incubated with SEQ ID NO: 474.

(68) FIG. 69 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 504.

(69) FIG. 70 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID NO: 114.

(70) FIG. 71 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID NO: 505.

(71) FIG. 72 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID NO: 482.

(72) FIG. 73 shows an increase in HGF cell proliferation of 106% when incubated with SEQ ID NO: 479.

(73) FIG. 74 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 477.

(74) FIG. 75 shows an increase in HGF cell proliferation of 73% when incubated with SEQ ID NO: 410.

(75) FIG. 76 shows an increase in HGF cell proliferation of 69% when incubated with SEQ ID NO: 475.

(76) FIG. 77 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID NO: 497.

(77) FIG. 78 shows an increase in HGF cell proliferation of 102% when incubated with SEQ ID NO: 480.

(78) FIG. 79 shows an increase in HGF cell proliferation of 100% when incubated with SEQ ID NO: 463.

(79) FIG. 80 shows an increase in HGF cell proliferation of 96% when incubated with SEQ ID NO: 465.

(80) FIG. 81 shows an increase in HGF cell proliferation of 90% when incubated with SEQ ID NO: 467.

(81) FIG. 82 shows an increase in HGF cell proliferation of 85% when incubated with SEQ ID NO: 461.

(82) FIG. 83 shows an increase in HGF cell proliferation of 83% when incubated with SEQ ID NO: 341.

(83) FIG. 84 shows an increase in HGF cell proliferation of 82% when incubated with SEQ ID NO: 468.

(84) FIG. 85 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 485.

(85) FIG. 86 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID NO: 496.

(86) FIG. 87 shows an increase in HGF cell proliferation of 80% when incubated with SEQ ID NO: 146.

(87) FIG. 88 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID NO: 478.

(88) FIG. 89 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID NO: 452.

(89) FIG. 90 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID NO: 495.

(90) FIG. 91 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID NO: 403.

(91) FIG. 92 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID NO: 455.

(92) FIG. 93 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID NO: 270.

(93) FIG. 94 shows an increase in HGF cell proliferation of 43% when incubated with SEQ ID NO: 501.

(94) FIG. 95 shows an increase in HGF cell proliferation of 41% when incubated with SEQ ID NO: 473.

(95) FIG. 97 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 471.

(96) FIG. 98 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID NO: 460.

(97) FIG. 99 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID NO: 93.

(98) FIG. 100 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID NO: 462.

Example 2—Collagen Production Assay

(99) Hydroxyproline in tissue preparations is a direct measure of the amount of collagen present. FIRELISA Human Hydroxyproline ELISA kit assay is designed to measure hydroxyproline in tissue or peptide compositions.

(100) Human Dermal Fibroblasts (HDF Sigma 10605a) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

(101) Following the initial 24 h incubation the cells were incubated with 5 μg/ml, 1 μg/ml or 0.1 μg/ml synthetic peptide for 96 h respectively.

(102) After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 μl/ml of each supernatant was assayed using the FIRELISA Human Hydroxyproline ELISA kit. All steps were carried out according to the manufacturer's instructions.

(103) Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content.

(104) The results are shown in FIGS. 102, 104, 106 and 109

Example 3—Elastin Production Assay

(105) Elastin is a highly elastic protein in connective tissue and allows many tissues in the body to resume their shape after stretching or contracting. FIRELISA Human Elastin ELISA kit assay is designed to measure Elastin in tissue or protein/peptide compositions.

(106) Human Dermal Fibroblasts (HDF) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24 h.

(107) Following the initial 24 h incubation the cells were incubated with 5 μg/ml, 1 μg/ml or 0.1 μg/ml synthetic peptide for 96 h respectively.

(108) After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 μl/ml of each supernatant was assayed using the FIRELISA Human Elastin ELISA kit. All steps were carried out according to the manufacturer's instructions.

(109) Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content.

(110) The results are shown in FIGS. 101, 103, 105, 107, 108 and 109.

Example 4—Elastin and Cell Proliferation Assays

(111) TABLE-US-00005 TABLE 2 Test items. Peptide 6 and Peptide 7 correspond to samples dissolved into DMSO 0.3% instead of water. Intertek Item Denomination Concentration Provider Nature reference Solubility Storage Peptide 1 E_280_PJ 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-01 Peptide 2 I_222two_IN 20 μM Nuritas Peptide 14-CHL- Water Ambient 0723-02 Peptide 3 E_134_two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-03 Peptide 4 E_30two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-04 Peptide 5 E_121two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-05 Peptide 6 I_10two_IN 20 μM Nuritas Peptide 14-CHL- DMSO −80° C. 0723-06 0.3% Peptide 7 I_41two_IN 20 μM Nuritas Peptide 14-CHL- DMSO −80° C. 0723-07 0.3% Peptide 8 E_41_PJ 10 μM* Nuritas Peptide 14-CHL- Water −80° C. 0723-08 Composition P9 E_2_IN 500 μg/mL Nuritas Composition 14-CHL- Water −80° C. of peptides 0723-09 Composition P10 I_2_IN 500 μg/mL Nuritas Composition 14-CHL- Water −80° C. of peptides 0723-10

(112) Equipment

(113) Incubator, Flow Laminar Chamber, Sterile Polished Plastic Rod, Pipettor, Maintenance medium, Plate 6 well, Plate 24 well.

(114) Reagents

(115) MTT, PBS, SDS, Formaldehyde, Xylene, Ethanol absolute, Dulbecco's phosphate-buffered saline (DPBS), Metal Enhanced DAB substrate kit, ABC peroxidase staining kit, Citric acid, Sodium hydroxide 2N, Hydrogen peroxide 30%, Anti-Filaggrin, Anti-rabbit IgG-Biotin, Tween 20.

(116) Test System

(117) Nature: Human skin tissue 5 mm diameter

(118) Batch number: EXP004050B009 and EXP004050B011

(119) Provider: Laboratoire Biopredic International—8-18 rue Jean Pecker—35000 Rennes—France. Tel: +33 (0)2.99.14.36.14-Fax: +33 (0)2.99.54.44.72.

(120) Certificates of analysis are present in Annex 1.

(121) Two batches are used for the assay. Batch EXP004050B.sub.005 is used for experiment day 1, and Batch EXP004050B006 is used for experiment day 5.

(122) Maintenance Medium

(123) Maintenance Medium: Batch no: MIL 218C

(124) Provider: Laboratoire Biopredic International—8-18 rue Jean Pecker—35000 Rennes—France.

(125) TABLE-US-00006 Peptides Tested P1: SEQ ID NO: 283 P2: SEQ ID NO: 246 P3: SEQ ID NO: 284 P4: (SEQ ID NO: 776) RPYYSNAPQEIF P5: (SEQ ID NO: 777) VLLEQQEQEPQH P6: SEQ ID NO: 245 P7: (SEQ ID NO: 778) QQYGIAASPFLQSAA P8: SEQ ID NO: 42

(126) Compositions Tested

(127) P9 (14-CHL-0723-09) is the Pea composition (SEQ ID NOs: 50, 85, 74, 140, 82, 136, 189, 77, 169, 149, 171, 178, 143, 127, 190, 141, 147, 133, 186, 125, 122, 119, 87, 90, 86, 89, 138, 129, 123, 120, 117, 113, 110, 121, 105, 98, 55, 161, 19, 317, 135, 130, 146, 177, 160, 170, 188, 83, 78, 36, 96, 159, 26, 330, 168, 148, 184, 151, 151, 165, 114, 284)

(128) P10 (14-CHL-0723-010) is the Rice composition (SEQ ID NOs: 245, 246, 263, 250, 257, 259, 276, 255, 251, 264, 256, 266, 274, 270, 269, 356, 245, 380, 262, 258, 356, 218, 252, 358, 271, 253, 344, 275, 272, 226, 224, 220, 248, 261, 265, 373, 375, 247, 249, 363, 273, 343, 273, 362)

(129) Application Method

(130) Skin explants were prepared from abdominal plastic surgery. Some explants were delipidated with alcohol to obtain a dehydrated skin.

(131) These explants were maintained in maintenance medium supplied by the provider Bioprédic International for 5 days. Test items are applied twice per day with 5 μL per explant.

(132) At the end of the test, viabilities controls are realized with the MTT on two explants, the third explant is fixed in the formaldehyde 4% for histology and cell staining.

(133) For each time of analysis (D1 and D5), histologies on delipidated explants, treated explants with test items, the DMSO 0.3% control and water control, are performed.

(134) After receipt in the laboratory, each skin explant in the maintenance medium is delipidated with 5 μL alcohol during 3 hours.

(135) After 3 hours, all skin explants are treated two per day with test items, and they are incubated at 37° C.+/−2° C., 5% CO2 for 1 day or 5 days. Integrity of the system is realized at day 1 and day 5 with a viability control with MTT.

(136) Immunostaining

(137) Histology is realized by the laboratory Gredeco and the immunostaining to elastin and Ki67 are realized by the same laboratory. Immunostaining to filaggrin is realized by the laboratory Intertek.

(138) The detection of elastin (rabbit monoclonal antibody, clone P15502, LSBio) is performed using an immunoperoxidase technique two layers (ABC kit, Vector Laboratories) and revealed by AEC (3-amino-9-éthylcarbazole). The immunohistochemical staining intensity in the elastic fibers is evaluated using a semi-quantitative histological score.

(139) Epithelial proliferation was analyzed by immunohistochemistry using anti-Ki67 antibody.

(140) Immunodetection was performed using an indirect immunoperoxidase technique three layers, amplified (DAKO kit) and revealed by AEC (3-Amino-9-ethylcarbazole). Counting the number of labeled cells (keratinocytes of the basal layer of the epidermis) is performed and provides the total number of basal cells to calculate the % of labeled cells.

(141) The specific staining of filaggrin is performed with an immunoperoxidase staining (ABC kit, Fisher). The intensity of immunohistochemical marker in the epidermis is evaluated relative to the negative control of the solvent (Water or DMSO 0.3%).

(142) C: Results

(143) Viability Control

(144) The integrity control and the viability control are present in FIG. 1. These controls do allow to validate the assay system. The viability is >50% for test items, and they do not show a cytotoxicity according to the test.

(145) Immunostaining

(146) Elastin Expression

(147) The elastic fibers of the dermis were revealed by staining with the catechin and morphometrically quantified by analysis by computer-assisted image. The percentage area taken up by elastic fibers in the dermis was calculated in the dermis and the average superficial dermis. Results are presented in FIGS. 101, 105, 107, and 108.

(148) TABLE-US-00007 TABLE 3 Morphometric quantification of elastic fibers in the superficial dermis (%) and middle dermis. All samples dissolved in water except where indicated. Morphometric Morphometric quantification of elastic quantification of elastic fibers in the superficial fibers in the middle dermis (%) dermis (%) Conditions D 1 D 5 D 1 D 5 Dehydrated with alcohol and hydrated with 4.31 4.9 5 5.83 water Dehydrated 2.38 7.26 4.39 9.59 EGF (Epidermal Growth Factor) 10 ng/mL 3.64 5.61 5.68 6,.61 Dehydrated with alcohol and hydrated with 3.76 7.24 6 10.36 DMSO 0.3% 0723.01 4.45 10.21 7.59 10.17 0723.02 6.09 7.59 11.,75 9.08 0723.03 3 11.68 4.9 9 0723.04 3.28 8.94 5.22 9 0723.05 6.34 6.26 8.8 6.61 0723.06 (dissolved into DMSO 0.3% 3.8 4.03 4.54 8.67 instead of water) 0723.07 (dissolved into DMSO 0.3% 4 5.15 6.46 5.33 instead of water) 0723.08 2.7 5.32 3.52 7.27 0723.09 3.26 8.26 5.75 7.92 0723.10 4.1 8 5.73 8.34

(149) Under the experimental conditions of the study, 0723-1 and 0723-3 samples show an increase by twice of elastic fibers in the superficial dermis compared to control water (Figure), and an increase in the middle dermis compared to the water control at D5.

(150) The 0723-2 sample shows an increase doubled in the middle dermis at day 1 compared to control water and an increase at day 5.

(151) Ki67 Expression

(152) The results of the immunohistochemical analysis of Ki67 are reported in Table 4 and expressed as % of labelled at the basal layer of the epidermis. The FIG. 115 shows the percentage of Ki 67 cells compared to negative controls (water or DMSO). Immunohistochemical analysis of mitotic activity is shown in annex 4 with a reminder of the average for each analysed conditions.

(153) TABLE-US-00008 TABLE 4 % of Ki67 positive cells in the basal layer of the epidermis. All samples dissolved in water except where indicated. Conditions D 1 D 5 Dehydrated with alcohol and hydrated with 19.09 3.53 water Dehydrated 17.05 1.76 EGF (Epidermal Growth Factor) 10 ng/mL 25.11 4.2 Dehydrated with alcohol and hydrated with 17.2 2.61 DMSO 0.3% 0723.01 18.57 3.92 0723.02 19.61 6.73 0723.03 22.01 10.04 0723.04 14.97 11.36 0723.05 9.48 3.08 0723.06 (dissolved into DMSO 0.3% instead 31.97 5.04 of water) 0723.07 (dissolved into DMSO 0.3% instead 22.22 5.26 of water) 0723.08 27.83 5.72 0723.09 31.02 2.4 0723.10 31.94 3.57

(154) Under the experimental conditions of the study, test item 0723-06, 0723-08, 0723-09 and 0723-010 show an increase in the number of mitotic cells compared to EGF at day 1. A decrease in the mitotic index was observed on day 5 compared to day 1 for all analysed conditions.

(155) The decrease in this cell staining on day 5 is caused by the model. Indeed, after approximately 3 days cell turnover is exhausted on this model.

(156) The invention is not limited to the embodiments hereinbefore described which may be varied in construction and detail without departing from the spirit of the invention.

(157) TABLE-US-00009 SEQUENCES PROTEIN: P13918-2-PEA MAATTMKASFPLLMLMGISFLASVCVSSRSDPQNPFIFKSNKFQTLFENENGHIRLLQKFDQRSKIFENLQNYRLLEYKSKPHTIFLPQHTDADYI LVVLSGKAILTVLKPDDRNSFNLERGDTIKLPAGTIAYLVNRDDNEELRVLDLAIPVNRPGQLQSFLLSGNQNQQNYLSGFSKNILEASFNTDYEE IEKVLLEEHEKETQHRRSLKDKRQQSQEENVIVKLSRGQIEELSKNAKSTSKKSVSSESEPFNLRSRGPIYSNEFGKFFEITPEKNPQLQDLDIFVNS VEIKEGSLLLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQEQRKEDDEEEEQGEEEINKQVQNYKAKLSSGDVFVIPAGHPVAVKASSNLDLL GFGINAENNQRNFLAGDEDNVISQIQRPVKELAFPGSAQEVDRILENQKQSHFADAQPQQRERGSRETRDRLSSV [SEQ ID NO: 1] PEPTIDE: QNYLSGFSKNILE [SEQ ID NO: 15] PEPTIDE: TIKLPAGTIAYLVNRDDNEE [SEQ ID NO: 16] PEPTIDE: LAIPVNRPGQLQSFL [SEQ ID NO: 17] PEPTIDE: AIPVNRPGQLQ [SEQ ID NO: 18] PEPTIDE: PAGHPVAVK [SEQ ID NO: 19] PEPTIDE: VQNYKAKLSSGDVFVIPAG [SEQ ID NO: 20] PEPTIDE: NNQRNFLAGDEDNVISQIQRPVKE [SEQ ID NO: 21] PEPTIDE: INKQVQNYKAKLSSGDVFVIPAG [SEQ ID NO: 22] PEPTIDE: LAIPVNRPGQ [SEQ ID NO: 23] PEPTIDE: NFLAGDEDNVISQIQRPVKE [SEQ ID NO: 24] PEPTIDE: DLAIPVNRPGQLQSF [SEQ ID NO: 25] PEPTIDE: VIPAGHPVAVK [SEQ ID NO: 26] PEPTIDE: DTIKLPAGTIAYLVNRDDNEE [SEQ ID NO: 27] PEPTIDE: LAIPVNRPGQLQSF [SEQ ID NO: 28] PEPTIDE: KQVQNYKAKLSSGDVFVIPAG [SEQ ID NO: 29] PEPTIDE: RGDTIKLPAGTIAYLVNRDDNEE [SEQ ID NO: 30] PEPTIDE: FLAGDEDNVISQIQRPVKE [SEQ ID NO: 31] PEPTIDE: LAIPVNRPGQLQS [SEQ ID NO: 32] PEPTIDE: VLDLAIPVNRPGQLQ [SEQ ID NO: 33] PEPTIDE: DLAIPVNRPGQLQ [SEQ ID NO: 34] PEPTIDE: VFVIPAGHPVAVK [SEQ ID NO: 35] PEPTIDE: TIFLPQHTDADYILVVLSGK [SEQ ID NO: 36] PEPTIDE: NQRNFLAGDEDNVISQIQRPVKE [SEQ ID NO: 37] PEPTIDE: LAIPVNRPGQLQ [SEQ ID NO: 38] PEPTIDE: HPVAVKASSNLDLLGFG [SEQ ID NO: 39] PEPTIDE: LAIPVNRPGQL [SEQ ID NO: 40] PEPTIDE: DLAIPVNRPGQL [SEQ ID NO: 41] PEPTIDE: SKPHTIFLPQHTDADYILVVLSGK [SEQ ID NO: 42] PEPTIDE: FVIPAGHPVAVK [SEQ ID NO: 43] PEPTIDE: DLAIPVNRPGQLQS [SEQ ID NO: 44] PEPTIDE: SGDVFVIPAGHPVAVKASSNLD [SEQ ID NO: 45] PEPTIDE: AIPVNRPGQLQSF [SEQ ID NO: 46] PEPTIDE: ELAFPGSAQEVDR [SEQ ID NO: 47] PEPTIDE: LAIPVNRPGQLQSFLLSG [SEQ ID NO: 48] PEPTIDE: VFVIPAGHPVAVKASSNLDLLGFG [SEQ ID NO: 49] PEPTIDE: AGHPVAVK [SEQ ID NO: 50] PEPTIDE: HPVAVKASSNLDLLGFGINAE [SEQ ID NO: 51] PEPTIDE: LAIPVNRPGQLQSFLLSGNQNQ [SEQ ID NO: 52] PEPTIDE: SGDVFVIPAG [SEQ ID NO: 53] PEPTIDE: GSLLLPHYNSRAIVIVTVNE [SEQ ID NO: 54] PEPTIDE: NFLAGDEDNVISQIQRPVK [SEQ ID NO: 55] PEPTIDE: SGDVFVIPAGHPVA [SEQ ID NO: 56] PEPTIDE: GSLLLPHYNSRAIVIV [SEQ ID NO: 57] PEPTIDE: RGDTIKLPAGTIAYLVNRDD [SEQ ID NO: 58] PEPTIDE: SGDVFVIPAGHPVAVK [SEQ ID NO: 59] PEPTIDE: LSSGDVFVIPAGHPVAVK [SEQ ID NO: 60] PEPTIDE: LDLAIPVNRPGQL [SEQ ID NO: 61] PEPTIDE: AIPVNRPGQL [SEQ ID NO: 62] PEPTIDE: LAIPVNRPGQLQSFLL [SEQ ID NO: 63] PEPTIDE: PHTIFLPQHTDADYILVVLSGK [SEQ ID NO: 64] PEPTIDE: VFVIPAGHPVAVKASSNLD [SEQ ID NO: 65] PEPTIDE: LAIPVNRPGQLQSFLLS [SEQ ID NO: 66] PEPTIDE: VLDLAIPVNRPGQLQSF [SEQ ID NO: 67] PEPTIDE: AIPVNRPGQLQS [SEQ ID NO: 68] PEPTIDE: DTIKLPAGTIAYLVNRDDNE [SEQ ID NO: 69] PEPTIDE: NYKAKLSSGDVFVIPAG [SEQ ID NO: 70] PEPTIDE: GKAILTVLKPDDRNSFNLE [SEQ ID NO: 71] PEPTIDE: YKSKPHTIFLPQHTDAD [SEQ ID NO: 72] PEPTIDE: ASSNLDLLGFG [SEQ ID NO: 73] PEPTIDE: DEEEEQGEEEINK [SEQ ID NO: 74] PEPTIDE: YKSKPHTIFLPQHTD [SEQ ID NO: 75] PEPTIDE: VLDLAIPVNR [SEQ ID NO: 76] PEPTIDE: FFEITPEKNPQLQDLDIFVNSVEIK [SEQ ID NO: 77] PEPTIDE: TIFLPQHTDADYIL [SEQ ID NO: 78] PEPTIDE: SFLLSGNQNQQNYLSG [SEQ ID NO: 79] PEPTIDE: SFLLSGNQNQQNYLSGFS [SEQ ID NO: 80] PEPTIDE: NQQEQRKEDDEEEEQGEEE [SEQ ID NO: 81] PEPTIDE: EEQGEEEINK [SEQ ID NO: 82] PEPTIDE: SRGPIYSNE [SEQ ID NO: 83] PEPTIDE: EDDEEEEQGEEEINK [SEQ ID NO: 84] PEPTIDE: DDEEEEQGEEEINK [SEQ ID NO: 85] PEPTIDE: KEDDEEEEQGEEEIN [SEQ ID NO: 86] PEPTIDE: KEDDEEEEQGEE [SEQ ID NO: 87] PEPTIDE: QRKEDDEEEEQGEEE [SEQ ID NO: 88] PEPTIDE: KEDDEEEEQGEEEINK [SEQ ID NO: 89] PEPTIDE: KEDDEEEEQGEEE [SEQ ID NO: 90] PROTEIN: Q9M3X6-3-PEA MATTIKSRFPLLLLLGIIFLASVVCVTYANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSYEKEEDEEEGQRERGRQEGEKEEKRHGEWR PSYEKQEDEEEKQKYRYQREKEDEEEKQKYQYQREKKEQKEVQPGRERWEREEDEEQVDEEWRGSQRREDPEERARLRHREERTKRDRRHQ REGEEEERSSESQERRNPFLFKSNKFLTLFENENGHIRLLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLILVVLSGKAILTVLSPNDR NSYNLERGDTIKLPAGTTSYLVNQDDEEDLRLVDLVIPVNGPGKFEAFDLAKNKNQYLRGFSKNILEASYNTRYETIEKVLLEEQEKDRKRRQQG EETDAIVKVSREQIEELKKLAKSSSKKSLPSEFEPINLRSHKPEYSNKFGKLFEITPEKKYPQLQDLDLFVSCVEINEGALMLPHYNSRAIVVLLVNEG KGNLELLGLKNEQQEREDRKERNNEVQRYEARLSPGDVVIIPAGHPVAITASSNLNLLGFGINAENNERNFLSGSDDNVISQIENPVKELTFPGS VQEINRLIKNQKQSHFANAEPEQKEQGSQGKRSPLSSILGTFY [SEQ ID NO: 2] PEPTIDE: HPVAITASSNLNLLG [SEQ ID NO: 91] PEPTIDE: ASSNLNLLGFG [SEQ ID NO: 92] PEPTIDE: ITASSNLNLLGFG [SEQ ID NO: 93] PEPTIDE: ITASSNLNLLGFGINAE [SEQ ID NO: 94] PEPTIDE: SSNLNLLGFG [SEQ ID NO: 95] PEPTIDE: VDLVIPVNGPGKF [SEQ ID NO: 96] PEPTIDE: LVIPVNGPGKFE [SEQ ID NO: 97] PEPTIDE: LVIPVNGPGKFEA [SEQ ID NO: 98] PEPTIDE: LRLVDLVIPVNGPGKFE [SEQ ID NO: 99] PEPTIDE: YRAKPHTIFLPQHIDAD [SEQ ID NO: 100] PEPTIDE: HPVAITASSNLNLLGFGINAE [SEQ ID NO: 101] PEPTIDE: SNLNLLGFG [SEQ ID NO: 102] PEPTIDE: HPVAITASSNLNLLGFGINAENNE [SEQ ID NO: 103] PEPTIDE: LVDLVIPVNGPGKFE [SEQ ID NO: 104] PEPTIDE: LVIPVNGPGKF [SEQ ID NO: 105] PEPTIDE: TIKLPAGTTSYLVNQDDE [SEQ ID NO: 106] PEPTIDE: DLRLVDLVIPVNGPGKFE [SEQ ID NO: 107] PEPTIDE: EDLRLVDLVIPVNGPGKFE [SEQ ID NO: 108] PEPTIDE: HPVAITASSNLNLLGFG [SEQ ID NO: 109] PEPTIDE: LVDLVIPVNGPGKFEAFDLAK [SEQ ID NO: 110] PEPTIDE: DNVISQIENPVKE [SEQ ID NO: 111] PEPTIDE: VVIIPAGHPVAITASSNLNLLGFG [SEQ ID NO: 112] PEPTIDE: LVDLVIPVNGPGKFEAF [SEQ ID NO: 113] PEPTIDE: YPQLQDLDL [SEQ ID NO: 114] PEPTIDE: VIPVNGPGKF [SEQ ID NO: 115] PEPTIDE: SKKSLPSE [SEQ ID NO: 116] PEPTIDE: LPQHIDADLILVVLSGK [SEQ ID NO: 117] PEPTIDE: RGDTIKLPAGTTSYLVNQD [SEQ ID NO: 118] PEPTIDE: IPVNGPGKF [SEQ ID NO: 119] PEPTIDE: LPQHIDADL [SEQ ID NO: 120] PEPTIDE: LVIPVNGPGK [SEQ ID NO: 121] PEPTIDE: IFLPQHIDAD [SEQ ID NO: 122] PEPTIDE: LPQHIDAD [SEQ ID NO: 123] PEPTIDE: VIPVNGPGK [SEQ ID NO: 124] PEPTIDE: IFLPQHIDA [SEQ ID NO: 125] PEPTIDE: TIKLPAGTTSYLVNQDDEE [SEQ ID NO: 126] PEPTIDE: HGEWRPSYEKEEDEEEGQRER [SEQ ID NO: 127] PEPTIDE: EKRHGEWRPSYEKEEDEEEGQRE [SEQ ID NO: 128] PEPTIDE: LPAGTTSYLVNQDDEEDLR [SEQ ID NO: 129] PEPTIDE: PSYEKEEDEEEGQRER [SEQ ID NO: 130] PEPTIDE: EKRHGEWRPSYE [SEQ ID NO: 131] PEPTIDE: TIKLPAGTTSYLVNQDDEED [SEQ ID NO: 132] PEPTIDE: HGEWRPSYEKQEDEEEK [SEQ ID NO: 133] PEPTIDE: EWRPSYEKEEDEEE [SEQ ID NO: 134] PEPTIDE: PSYEKEEDEEEGQR [SEQ ID NO: 135] PEPTIDE: EKEEDEEEGQR [SEQ ID NO: 136] PEPTIDE: EWRPSYEKEEDEEEGQRE [SEQ ID NO: 137] PEPTIDE: KEEDEEEGQR [SEQ ID NO: 138] PEPTIDE: VQPGRERWEREEDEEQVDE [SEQ ID NO: 139] PEPTIDE: DVVIIPAGHPVA [SEQ ID NO: 140] PEPTIDE: HGEWRPSYEKQEDE [SEQ ID NO: 141] PEPTIDE: EEDEEEGQR [SEQ ID NO: 142] PEPTIDE: HGEWRPSYEKEEDEEEGQR [SEQ ID NO: 143] PEPTIDE: EEWRGSQRREDPEE [SEQ ID NO: 144] PEPTIDE: REEDEEQVDEEWRGSQRREDPEE [SEQ ID NO: 145] PEPTIDE: RHGEWRPSY [SEQ ID NO: 146] PEPTIDE: HGEWRPSYEKQEDEE [SEQ ID NO: 147] PEPTIDE: VVIIPAGHPVA [SEQ ID NO: 148] PEPTIDE: HGEWRPSYE [SEQ ID NO: 149] PEPTIDE: KEEDEEEGQRER [SEQ ID NO: 150] PEPTIDE: VVIIPAGHPVAIT [SEQ ID NO: 151] PEPTIDE: EKRHGEWRPSYEKEEDE [SEQ ID NO: 152] PEPTIDE: QVDEEWRGSQRREDPEE [SEQ ID NO: 153] PEPTIDE: GDTIKLPAGTTSYLVNQDDEEDLR [SEQ ID NO: 154] PEPTIDE: GSEPRVPAQRE [SEQ ID NO: 155] PEPTIDE: EEKRHGEWRPSYEKE [SEQ ID NO: 156] PEPTIDE: EWRPSYEKEEDEE [SEQ ID NO: 157] PEPTIDE: NYDEGSEPRVPAQRE [SEQ ID NO: 158] PEPTIDE: VIIPAGHPVAIT [SEQ ID NO: 159] PEPTIDE: RHGEWRPSYEK [SEQ ID NO: 160] PEPTIDE: NYDEGSEPR [SEQ ID NO: 161] PEPTIDE: WRPSYEKEEDEE [SEQ ID NO: 162] PEPTIDE: WRPSYEKQEDEEE [SEQ ID NO: 163] PEPTIDE: EKRHGEWRPSYEKQEDEEE [SEQ ID NO: 164] PEPTIDE: VVIIPAGHPVAITA [SEQ ID NO: 165] PEPTIDE: KRHGEWRPSYE [SEQ ID NO: 166] PEPTIDE: GSDDNVISQIENPVKE [SEQ ID NO: 167] PEPTIDE: VVIIPAGHPV [SEQ ID NO: 168] PEPTIDE: HGEWRPSY [SEQ ID NO: 169] PEPTIDE: RPSYEKEEDEEEGQR [SEQ ID NO: 170] PEPTIDE: HGEWRPSYEK [SEQ ID NO: 171] PEPTIDE: KRHGEWRPSYEKEE [SEQ ID NO: 172] PEPTIDE: VVIIPAGHPVAITAS [SEQ ID NO: 173] PEPTIDE: RGDTIKLPAGTTSYLVNQDDEED [SEQ ID NO: 174] PEPTIDE: KRHGEWRPSYEKQEDEEE [SEQ ID NO: 175] PEPTIDE: DEEQVDEEWRGSQRREDPEE [SEQ ID NO: 176] PEPTIDE: RHGEWRPSYE [SEQ ID NO: 177] PEPTIDE: HGEWRPSYEKE [SEQ ID NO: 178] PEPTIDE: KRHGEWRPSYEKEEDEEE [SEQ ID NO: 179] PEPTIDE: EKRHGEWRPSYEKEEDEEE [SEQ ID NO: 180] PEPTIDE: TIKLPAGTTSYLVNQDDEEDLRLVD [SEQ ID NO: 181] PEPTIDE: WRPSYEKEEDEEEGQRE [SEQ ID NO: 182] PEPTIDE: KRHGEWRPSYEKEEDEE [SEQ ID NO: 183] PEPTIDE: VVIIPAGHPVAI [SEQ ID NO: 184] PEPTIDE: EWRGSQRREDPEE [SEQ ID NO: 185] PEPTIDE: HGEWRPSYEKQEDEEEKQK [SEQ ID NO: 186] PEPTIDE: SGSDDNVISQIENPVKE [SEQ ID NO: 187] PEPTIDE: RPSYEKEEDEEEGQRER [SEQ ID NO: 188] PEPTIDE: EKEEDEEEGQRER [SEQ ID NO: 189] PEPTIDE: HGEWRPSYEKQ [SEQ ID NO: 190] PEPTIDE: WRPSYEKEEDEEE [SEQ ID NO: 191] PEPTIDE: LAKNKNQYLRGFS [SEQ ID NO: 192] PEPTIDE: NKNQYLRGFS [SEQ ID NO: 193] PEPTIDE: LRGFSKNILE [SEQ ID NO: 194] PEPTIDE: LAKNKNQYLRGFSKN [SEQ ID NO: 195] PEPTIDE: TVLSPNDRNSY [SEQ ID NO: 196] PEPTIDE: QYLRGFSKNILE [SEQ ID NO: 197] PEPTIDE: GKAILTVLSPNDRNSYNLE [SEQ ID NO: 198] PEPTIDE: RGFSKNILE [SEQ ID NO: 199] PEPTIDE: NKNQYLRGFSKNILE [SEQ ID NO: 200] PEPTIDE: ASSNLNLLGFGINAE [SEQ ID NO: 201] PEPTIDE: ASSNLNLLGF [SEQ ID NO: 202] PEPTIDE: LAKNKNQYLRGFSK [SEQ ID NO: 203] PEPTIDE: RGDTIKLPAGTTSYLVNQDDEE [SEQ ID NO: 204] PEPTIDE: ARLSPGDVVIIPAGHPVAITASSN [SEQ ID NO: 205] PEPTIDE: VQRYEARLSPGD [SEQ ID NO: 206] PEPTIDE: ARLSPGDVVIIPAGHPVAIT [SEQ ID NO: 207] PEPTIDE: RGDTIKLPAGTTSYLVNQDDE [SEQ ID NO: 208] PEPTIDE: ARLSPGDVVIIPAGHPVA [SEQ ID NO: 209] PEPTIDE: GALMLPHYNSRAIVVLLVNE [SEQ ID NO: 210] PEPTIDE: ARLSPGDVVIIPAGHPVAITASS [SEQ ID NO: 211] PEPTIDE: LSPGDVVIIPAGHPVAITASSNLNLLGFGINAENNER [SEQ ID NO: 212] PEPTIDE: ARLSPGDVVIIPAGHPVAITAS [SEQ ID NO: 213] PEPTIDE: LSPGDVVIIPAGHPVAITASSNL [SEQ ID NO: 214] PEPTIDE: ARLSPGDVVIIPAGHPVAITA [SEQ ID NO: 215] PROTEIN: Q0DEV5-5-RICE MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKIY GPDTGVDYKDNQMRFSLLCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAFE DYPELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYITA KYDATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKFNA PLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKVVGTPAYEE MVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAPLAKENVAAP [SEQ ID NO: 3] PEPTIDE: NWENVLLGLGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 216] PEPTIDE: YDQYKDAWDTSVVAEIK [SEQ ID NO: 217] PEPTIDE: SSFDFIDGYDTPVEGR [SEQ ID NO: 218] PEPTIDE: GPDTGVDYKDNQM [SEQ ID NO: 219] PEPTIDE: ILNLNNNPYFK [SEQ ID NO: 220] PEPTIDE: VVGTPAYEE [SEQ ID NO: 221] PEPTIDE: IDGYDTPVEGR [SEQ ID NO: 222] PEPTIDE: VVGTPAYE [SEQ ID NO: 223] PEPTIDE: IYGPDTGVDYK [SEQ ID NO: 224] PEPTIDE: VAGSAPGIEGDE [SEQ ID NO: 225] PEPTIDE: IYGPDTGVDYKDNQMR [SEQ ID NO: 226] PEPTIDE: VVGTPAYEEMVR [SEQ ID NO: 227] PEPTIDE: DFIDGYDTPVEGR [SEQ ID NO: 228] PEPTIDE: LGLGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 229] PEPTIDE: FNAPLAHLIMAGADVLAVPSR [SEQ ID NO: 230] PEPTIDE: LGLGVAGSAPGIEGDE [SEQ ID NO: 231] PEPTIDE: LGLGVAGSAPGIEGDEIAPL [SEQ ID NO: 232] PEPTIDE: VLTVSPYYAEELISGIAR [SEQ ID NO: 233] PEPTIDE: EALQAEAGLPVDR [SEQ ID NO: 234] PEPTIDE: LGLGVAGSAPGIEGD [SEQ ID NO: 235] PEPTIDE: IMAGADVLAVPSR [SEQ ID NO: 236] PEPTIDE: GLGVAGSAPGIEGDE [SEQ ID NO: 237] PEPTIDE: EALQAEAGLPVDRK [SEQ ID NO: 238] PEPTIDE: TGGLGDVLGGLPPAMAANGHR [SEQ ID NO: 239] PEPTIDE: LEEQKGPDVMA [SEQ ID NO: 240] PEPTIDE: LGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 241] PEPTIDE: GLGVAGSAPGIEGDEIAPLAK [SEQ ID NO: 242] PEPTIDE: TGGLGDVLGGLPPAM [SEQ ID NO: 243] PEPTIDE: NVLLGLGVAGSAPGIEGDE [SEQ ID NO: 244] PROTEIN: P14323-6-RICE MASSVFSRFSIYFCVLLLCHGSMAQLFNPSTNPWHSPRQGSFRECRFDRLQAFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLL VPRYTNIPGVVYIIQGRGSMGLTFPGCPATYQQQFQQFSSQGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNDGDAPIVAVYVYDV NNNANQLEPRQKEFLLAGNNNRAQQQQVYGSSIEQHSGQNIFSGFGVEMLSEALGINAVAAKRLQSQNDQRGEIIHVKNGLQLLKPTLTQQ QEQAQAQDQYQQVQYSERQQTSSRWNGLEENFCTIKVRVNIENPSRADSYNPRAGRITSVNSQKFPILNLIQMSATRVNLYQNAILSPFWNV NAHSLVYMIQGRSRVQVVSNFGKTVFDGVLRPGQLLIIPQHYAVLKKAEREGCQYIAIKTNANAFVSHLAGKNSVFRALPVDVVANAYRISRE QARSLKNNRGEEHGAFTPRFQQQYYPGLSNESESETSE [SEQ ID NO: 4] PEPTIDE: TVFDGVLRPGQL [SEQ ID NO: 245] PEPTIDE: RLQSQNDQRGEIIHVK [SEQ ID NO: 246] PROTEIN: P29835-5-RICE MASKVVFFAAALMAAMVAISGAQLSESEMRFRDRQCQREVQDSPLDACRQVLDRQLTGRERFQPMFRRPGALGLRMQCCQQLQDVSRE CRCAAIRRMVRSYEESMPMPLEQGWSSSSSEYYGGEGSSSEQGYYGEGSSEEGYYGEQQQQPGMTRVRLTRARQYAAQLPSMCRVEPQQC SIFAAGQY [SEQ ID NO: 5] PEPTIDE: EGYYGEQQQQPGMTR [SEQ ID NO: 247] PEPTIDE: GYYGEQQQQPGMTR [SEQ ID NO: 248] PEPTIDE: EEGYYGEQQQQPGMTR [SEQ ID NO: 249] PEPTIDE: YYGGEGSSSEQGYYGEGSSE [SEQ ID NO: 250] PEPTIDE: YGGEGSSSEQGYYGEGSSE [SEQ ID NO: 251] PEPTIDE: SSEEGYYGEQQQQPGMTR [SEQ ID NO: 252] PEPTIDE: SEEGYYGEQQQQPGMTR [SEQ ID NO: 253] PEPTIDE: QGYYGEGSSEE [SEQ ID NO: 254] PEPTIDE: YGGEGSSSEQGYYGEGSSEEGY [SEQ ID NO: 255] PEPTIDE: YGEQQQQPGMTR [SEQ ID NO: 256] PEPTIDE: YYGEQQQQPGMTR [SEQ ID NO: 257] PEPTIDE: SYEESMPMPLEQGWSSSSSE [SEQ ID NO: 258] PEPTIDE: YYGEGSSEEGYYGEQQQQPGMTR [SEQ ID NO: 259] PEPTIDE: QQQQPGMTRV [SEQ ID NO: 260] PEPTIDE: GEQQQQPGMTR [SEQ ID NO: 261] PEPTIDE: SYEESMPMPLEQGWSSSSSEY [SEQ ID NO: 262] PEPTIDE: YYGGEGSSSEQGYYGEGSSEEGY [SEQ ID NO: 263] PEPTIDE: YGEQQQQPGMTRVR [SEQ ID NO: 264] PEPTIDE: GEGSSEEGYYGEQQQQPGMTR [SEQ ID NO: 265] PEPTIDE: YGEGSSEEGYYGEQQQQPGMTR [SEQ ID NO: 266] PEPTIDE: QQQQPGMTRVR [SEQ ID NO: 267] PEPTIDE: QYAAQLPSMCRVEPQQCSIFAAGQY [SEQ ID NO: 268] PROTEIN: P0C1U8-5-Staphylococcus aureus MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQTQSSKQQTPKIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYI QVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTAEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMS NNAETQVNQNITVTGYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNEFNGAVFINENVRNFLKQ NIEDIHFANDDQPNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID NO: 14] PEPTIDE: APTGTFIASGVVVGKD [SEQ ID NO: 413] PEPTIDE: LAIVKFSPNEQNKHIGE [SEQ ID NO: 414] PEPTIDE: RHQITDTTNGHYAPVTYIQVE [SEQ ID NO: 415] PEPTIDE: GDLAIVKFSPNEQNKHIGE [SEQ ID NO: 416] PEPTIDE: NPDNPDNPNNPDNPNNPD [SEQ ID NO: 417] PROTEIN: P14614-4-RICE MATIAFSRLSIYFCVLLLCHGSMAQLFGPNVNPWHNPRQGGFRECRFDRLQAFEPLRRVRSEAGVTEYFDEKNEQFQCTGTFVIRRVIEPQGL LVPRYSNTPGMVYIIQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNEGDAPVVALYVF DLNNNANQLEPRQKEFLLAGNNNREQQMYGRSIEQHSGQNIFSGFNNELLSEALGVNALVAKRLQGQNDQRGEIIRVKNGLKLLRPAFAQQ QEQAQQQEQAQAQYQVQYSEEQQPSTRCNGLDENFCTIKARLNIENPSHADTYNPRAGRITRLNSQKFPILNLVQLSATRVNLYQNAILSPF WNVNAHSLVYIVQGHARVQVVSNLGKTVFNGVLRPGQLLIIPQHYVVLKKAEHEGCQYISFKTNANSMVSHLAGKNSIFRAMPVDVIANAYR ISREQARSLKNNRGEELGAFTPRYQQQTYPGFSNESENEALE [SEQ ID NO: 6] PEPTIDE: TVFNGVLRPGQL [SEQ ID NO: 269] PEPTIDE: TVFNGVLRPGQLL [SEQ ID NO: 270] PEPTIDE: SGFNNELLSEALGVNALVAK [SEQ ID NO: 271] PEPTIDE: NGVLRPGQL [SEQ ID NO: 272] PEPTIDE: ALVAKRLQGQN DQRG El [SEQ ID NO: 273] PEPTIDE: VPRYSNTPGM [SEQ ID NO: 274] PEPTIDE: PRYSNTPGMV [SEQ ID NO: 275] PEPTIDE: YSNTPGMVY [SEQ ID NO: 276] PEPTIDE: LVPRYSNTPGM [SEQ ID NO: 277] PEPTIDE: FYNEGDAPVV [SEQ ID NO: 278] PEPTIDE: FYNEGDAPVVAL [SEQ ID NO: 279] PEPTIDE: FEPLRRVRSEAGVTE [SEQ ID NO: 280] PEPTIDE: FYNEGDAPVVALY [SEQ ID NO: 281] PEPTIDE: FYNEGDAPVVA [SEQ ID NO: 282] PROTEIN: P09918-14-Pisum sativum MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTTVGGVIGQGFDILGSTVDNLTAFLGRSVSLQLISATKPDATGKGKLGKATFLEGIISSLPTLG AGQSAFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLDDIPNHGSIYFVCNSWIYNAKHHKIDRIFFANQTYLPSETPAPLVHYREEELNNLR GDGTGERKEWERIYDYDVYNDLGNPDSGENHARPVLGGSETYPYPRRGRTGRKPTRKDPNSESRSDYVYLPRDEAFGHLKSSDFLTYGLKAVS QNVVPALESVFFDLNFTPNEFDSFDEVHGLYEGGIKLPTNILSQISPLPVLKEIFRTDGENTLKYPPPKVIQVSRSGWMTDEEFAREMLAGVNPN VICCLQEFPPRSKLDSQIYGDHTSKISKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTSTKAYATRTILFLNNNQNLKPLAIELSLPHP QGDEHGAVSYVYQPALEGVESSIWLLAKAYVIVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSCLHPIYKLLYPHYRDTMNINSLARLSLVND GGIIEKTFLWGRYSMEMSSKVYKNWVFTEQALPADLIKRGMAIEDPSSPCGVKLVVEDYPYAVDGLEIWAIIKTWVQDYVSLYYTSDEKLRQD SELQAWWKELVEVGHGDKKNEPWWPKMQTREDLIEVCSIVIWTASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEFEELVKSPQKA YLKTITPKFQTLIDLSVIEILSRHASDELYLGERDNPNWTSDKRALEAFKKFGNKLAEIEKKLTQRNNDEKLRNRHGPVEMPYTLLYPSSKEGLTFR GIPNSISI [SEQ ID NO: 7] PEPTIDE: HGPVEMPYTLLYPSSK [SEQ ID NO: 283] PROTEIN: P02857-1-PEA MAKLLALSLSFCFLLLGGCFALREQPQQNECQLERLDALEPDNRIESEGGLIETWNPNNKQFRCAGVALSRATLQRNALRRPYYSNAPQEIFIQ QGNGYFGMVFPGCPETFEEPQESEQGEGRRYRDRHQKVNRFREGDIIAVPTGIVFWMYNDQDTPVIAVSLTDIRSSNNQLDQMPRRFYLAG NHEQEFLQYQHQQGGKQEQENEGNNIFSGFKRDYLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIISPPEKQARHQRGSRQEEDED EEKQPRHQRGSRQEEEEDEDEERQPRHQRRRGEEEEEDKKERGGSQKGKSRRQGDNGLEETVCTAKLRLNIGPSSSPDIYNPEAGRIKTVTSL DLPVLRWLKLSAEHGSLHKNAMFVPHYNLNANSIIYALKGRARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSDRFSYVAFKTNDR AGIARLAGTSSVINNLPLDVVAATFNLQRNEARQLKSNNPFKFLVPARESENRASA [SEQ ID NO: 8] PEPTIDE: LDALEPDNR [SEQ ID NO: 284] PEPTIDE: DALEPDNR [SEQ ID NO: 285] PEPTIDE: HGSLHKNAMFVPHYNLNANSIIYA [SEQ ID NO: 286] PEPTIDE: LAGTSSVINNLPLDVVAATF [SEQ ID NO: 287] PEPTIDE: FREGDIIAVPTGIVFW [SEQ ID NO: 288] PEPTIDE: GTSSVINNLPLDVVAATFNLQRNE [SEQ ID NO: 289] PEPTIDE: KGAIVKVKGGLSIISPPE [SEQ ID NO: 290] PEPTIDE: RLAGTSSVINNLPLD [SEQ ID NO: 291] PEPTIDE: AGTSSVINNLPLDVVAATFNLQRNE [SEQ ID NO: 292] PEPTIDE: AGTSSVINNLPL [SEQ ID NO: 293] PEPTIDE: LAGTSSVINNLPLDVVA [SEQ ID NO: 294] PEPTIDE: AGTSSVINNLPLDV [SEQ ID NO: 295] PEPTIDE: AGRIKTVTSLDLPVLRW [SEQ ID NO: 296] PEPTIDE: AGRIKTVTSLDLPVLR [SEQ ID NO: 297] PEPTIDE: FREGDIIAVPTGIVF [SEQ ID NO: 298] PEPTIDE: AGTSSVINNLPLD [SEQ ID NO: 299] PEPTIDE: LAGTSSVINNLPL [SEQ ID NO: 300] PEPTIDE: LAGTSSVINNLPLDVV [SEQ ID NO: 301] PEPTIDE: EGDIIAVPTGIVF [SEQ ID NO: 302] PEPTIDE: LAGTSSVINNLPLDV [SEQ ID NO: 303] PEPTIDE: AGRALTVPQNYAVAAKSLSD [SEQ ID NO: 304] PEPTIDE: AGRALTVPQNYA [SEQ ID NO: 305] PEPTIDE: LAGTSSVINNLPLD [SEQ ID NO: 306] PEPTIDE: RAGIARLAGTSSVINNLPLDVVA [SEQ ID NO: 307] PROTEIN: P02855-4-PEA DNAEIEKILLEEHEKETHHRRGLRDKRQQSQEKNVIVKVSKKQIEELSKNAKSSSKKSVSSRSEPFNLKSSDPIYSNQYGKFFEITPKKNPQLQDLD IFVNYVEIKEGSLWLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEDDEEEEQREEETKNQVQSYKAKLTPGDVFVIPAGHPVAVRAS SNLNLLGFGINAENNQRNFLAGEEDNVISQIQKQVKDLTFPGSAQEVDRLLENQKQSYFANAQPQQRETRSQEIKEHLYSILGAF [SEQ ID NO: 9] PEPTIDE: RASSNLNLLGFGINAE [SEQ ID NO: 308] PEPTIDE: VTVNEGKGDFEL [SEQ ID NO: 309] PEPTIDE: VRASSNLNLLGFGINAE [SEQ ID NO: 310] PEPTIDE: VRASSNLNLLGFG [SEQ ID NO: 311] PEPTIDE: HPVAVRASSNLNLLGFG [SEQ ID NO: 312] PEPTIDE: TKNQVQSYKAKLTPGD [SEQ ID NO: 313] PEPTIDE: HPVAVRASSNLNLLG [SEQ ID NO: 314] PEPTIDE: KAKLTPGDVFVIPAG [SEQ ID NO: 315] PEPTIDE: DLTFPGSAQEVDRLLENQK [SEQ ID NO: 316] PEPTIDE: PAGHPVAVR [SEQ ID NO: 317] PEPTIDE: AKLTPGDVFVIPAGHPVA [SEQ ID NO: 318] PEPTIDE: SYKAKLTPGDVFVIPAGHPVA [SEQ ID NO: 319] PEPTIDE: LTPGDVFVIPAGHPVAVR [SEQ ID NO: 320] PEPTIDE: VQSYKAKLTPGDVFVIPAG [SEQ ID NO: 321] PEPTIDE: YKAKLTPGDVFVIPAGHPVA [SEQ ID NO: 322] PEPTIDE: FVIPAGHPVAVR [SEQ ID NO: 323] PEPTIDE: YKAKLTPGDVFVIPAG [SEQ ID NO: 324] PEPTIDE: DLTFPGSAQEVDR [SEQ ID NO: 325] PEPTIDE: AKLTPGDVFVIPAGHPVAVR [SEQ ID NO: 326] PEPTIDE: LTPGDVFVIPAG [SEQ ID NO: 327] PEPTIDE: SYKAKLTPGDVFVIPAG [SEQ ID NO: 328] PEPTIDE: SYKAKLTPGDVFVIPAGHPVAVR [SEQ ID NO: 329] PEPTIDE: VIPAGHPVAVR [SEQ ID NO: 330] PEPTIDE: QVQSYKAKLTPGDVFVIPAG [SEQ ID NO: 331] PEPTIDE: AKLTPGDVFVIPAG [SEQ ID NO: 332] PEPTIDE: HPVAVRASSNLNLLGFGINAE [SEQ ID NO: 333] PEPTIDE: YKAKLTPGDVFVIPAGHPVAVR [SEQ ID NO: 334] PEPTIDE: TKNQVQSYKAKLTPGDVFVIPAG [SEQ ID NO: 335] PEPTIDE: PFNLKSSDPIYS [SEQ ID NO: 336] PEPTIDE: IEKILLEE [SEQ ID NO: 337] PEPTIDE: SRSEPFNLKSSDPIYS [SEQ ID NO: 338] PEPTIDE: HPVAVRASSNLNL [SEQ ID NO: 339] PROTEIN: D3VNE1-5-PEA MAATPIKPLMLLAIAFLASVCVSSRSDQENPFIFKSNRFQTLYENENGHIRLLQKFDKRSKIFENLQNYRLLEYKSKPRTLFLPQYTDADFILVVLSG KATLTVLKSNDRNSFNLERGDTIKLPAGTIAYLANRDDNEDLRVLDLTIPVNKPGQLQSFLLSGTQNQPSLLSGFSKNILEAAFNTNYEEIEKVLLE QQEQEPQHRRSLKDRRQEINEENVIVKVSREQIEELSKNAKSSSKKSVSSESGPFNLRSRNPIYSNKFGKFFEITPEKNQQLQDLDIFVNSVDIKE GSLLLPNYNSRAIVIVTVTEGKGDFELVGQRNENQGKENDKEEEQEEETSKQVQLYRAKLSPGDVFVIPAGHPVAINASSDLNLIGFGINAENN ERNFLAGEEDNVISQVERPVKELAFPGSSHEVDRLLKNQKQSYFANAQPLQRE [SEQ ID NO: 10] PEPTIDE: TLFLPQYTDADFILVVLSGK [SEQ ID NO: 340] PROTEIN: P07728-1-RICE MASINRPIVFFTVCLFLLCNGSLAQQLLGQSTSQWQSSRRGSPRECRFDRLQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSVVRRVIEPRGL LLPHYTNGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLTESQSQSQKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIY VTDLNNGANQLDPRQRDFLLAGNKRNPQAYRREVEERSQNIFSGFSTELLSEALGVSSQVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQGQVQSRERYQEGQYQQSQYGSGCSNGLDETFCTLRVRQNIDNPNRADTYNPRAGRVTNLNTQNFPILSLVQMSAVKVNLYQNALLSPF WNINAHSVVYITQGRARVQVVNNNGKTVFNGELRRGQLLIIPQHYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPNDVLANAYRI SREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNAAESS [SEQ ID NO: 11] PEPTIDE: EVEERSQNIF [SEQ ID NO: 341] PEPTIDE: VEERSQNIFSGF [SEQ ID NO: 342] PEPTIDE: ASLQEQEQGQVQ [SEQ ID NO: 343] PEPTIDE: QEQEQGQVQSR [SEQ ID NO: 344] PEPTIDE: ASLQEQEQGQVQSR [SEQ ID NO: 345] PEPTIDE: EVEERSQNIFSGF [SEQ ID NO: 346] PEPTIDE: VTDLNNGANQLDPRQRD [SEQ ID NO: 347] PEPTIDE: VEHGLSLLQPYASL [SEQ ID NO: 348] PEPTIDE: IYVTDLNNGANQLDPRQRDFL [SEQ ID NO: 349] PEPTIDE: VTDLNNGANQLDPRQRDFL [SEQ ID NO: 350] PEPTIDE: VEHGLSLLQPYASLQEQEQGQVQSR [SEQ ID NO: 351] PEPTIDE: VTDLNNGANQLDPR [SEQ ID NO: 352] PEPTIDE: IYVTDLNNGANQLDPRQRD [SEQ ID NO: 353] PEPTIDE: YVTDLNNGANQLDPRQRDFL [SEQ ID NO: 354] PEPTIDE: YVTDLNNGANQLDPR [SEQ ID NO: 355] PEPTIDE: STELLSEALGVSSQVAR [SEQ ID NO: 356] PEPTIDE: HGLSLLQPYASLQEQE [SEQ ID NO: 357] PEPTIDE: SGFSTELLSEALGVSSQVAR [SEQ ID NO: 358] PROTEIN: P07730-2-RICE MASINRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDRLQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGLL LPHYTNGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAQLTESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYV TDINNGANQLDPRQRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQLQCQNDQRGEIVRVERGLSLLQPYASLQEQ EQGQMQSREHYQEGGYQQSQYGSGCPNGLDETFCTMRVRQNIDNPNRADTYNPRAGRVTNLNSQNFPILNLVQMSAVKVNLYQNALLSP FWNINAHSIVYITQGRAQVQVVNNNGKTVFNGELRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPTDVLANAYR ISREEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [SEQ ID NO: 12] PEPTIDE: GAFTPLQYKSYQD [SEQ ID NO: 359] PEPTIDE: GLLLPHYTNGASLVY [SEQ ID NO: 360] PEPTIDE: FLLAGNKRNPQAYRRE [SEQ ID NO: 361] PEPTIDE: ALPTDVLANAYR [SEQ ID NO: 362] PEPTIDE: DFLLAGNK [SEQ ID NO: 363] PEPTIDE: DVLANAYR [SEQ ID NO: 364] PEPTIDE: GAFTPLQYK [SEQ ID NO: 365] PEPTIDE: QGDVIALPAGVAHW [SEQ ID NO: 366] PEPTIDE: FGAFTPLQYKSY [SEQ ID NO: 367] PEPTIDE: FLLAGNKRNPQAYR [SEQ ID NO: 368] PEPTIDE: FGAFTPLQYKSYQ [SEQ ID NO: 369] PEPTIDE: GLSLLQPYASLQEQE [SEQ ID NO: 370] PEPTIDE: AFTPLQYK [SEQ ID NO: 371] PEPTIDE: FGAFTPLQYKSYQD [SEQ ID NO: 372] PEPTIDE: GDEFGAFTPLQYK [SEQ ID NO: 373] PEPTIDE: FGAFTPLQYKSYQDV [SEQ ID NO: 374] PEPTIDE: FGAFTPLQYK [SEQ ID NO: 375] PEPTIDE: FGAFTPLQYKS [SEQ ID NO: 376] PEPTIDE: VYIIQGRGITGPTF [SEQ ID NO: 377] PEPTIDE: YIIQGRGITGPTF [SEQ ID NO: 378] PEPTIDE: KTNPNSMVSHIAGK [SEQ ID NO: 379] PEPTIDE: TNPNSMVSHIAGK [SEQ ID NO: 380] PEPTIDE: PNSMVSHIAGKS [SEQ ID NO: 381] PEPTIDE: NIDNPNRADTYNPRAGRVTN [SEQ ID NO: 382] PEPTIDE: QRDFLLAGNKR [SEQ ID NO: 383] PEPTIDE: LLQPYASLQEQE [SEQ ID NO: 384] PEPTIDE: QRDFLLAGNK [SEQ ID NO: 385] PEPTIDE: QEQEQGQMQSR [SEQ ID NO: 386] PEPTIDE: SLLQPYASLQEQE [SEQ ID NO: 387] PEPTIDE: ASLQEQEQGQM [SEQ ID NO: 388] PEPTIDE: ASLQEQEQGQMQSR [SEQ ID NO: 389] PEPTIDE: DFLLAGNKR [SEQ ID NO: 390] PEPTIDE: QAFEPIRSVRSQAGTTEF [SEQ ID NO: 391] PEPTIDE: KTNPNSMVSHIAGKSSIF [SEQ ID NO: 392] PEPTIDE: VRRVIEPRGLLLPHYTNGASL [SEQ ID NO: 393] PEPTIDE: FGAFTPLQYKSYQDVYN [SEQ ID NO: 394] PEPTIDE: IALPAGVAHW [SEQ ID NO: 395] PEPTIDE: RVRQNIDNPNRADTYNPRAGRVTNL [SEQ ID NO: 396] PEPTIDE: NIDNPNRADTYNPRAGRVTNL [SEQ ID NO: 397] PEPTIDE: GAFTPLQYKSYQDVYN [SEQ ID NO: 398] PEPTIDE: PNSMVSHIAGKSSIFR [SEQ ID NO: 399] PEPTIDE: RLQAFEPIRSVRSQAGTTE [SEQ ID NO: 400] PEPTIDE: TNPNSMVSHIAGKSSIFR [SEQ ID NO: 401] PROTEIN: Q0D7S0-3-RICE MASNKVVFSVLLLAVVSVLAATATMAEYHHQDQVVYTPGPLCQPGMGYPMYPLPRCRALVKRQCVGRGTAAAAEQVRRDCCRQLAAVDD SWCRCEAISHMLGGIYRELGAPDVGHPMSEVFRGCRRGDLERAAASLPAFCNVDIPNGGGGVCYWLARSGY [SEQ ID NO: 13] PEPTIDE: ELGAPDVGHPM [SEQ ID NO: 402] PEPTIDE: LGAPDVGHPM [SEQ ID NO: 403] PEPTIDE: ELGAPDVGHPMSEVF [SEQ ID NO: 404] PEPTIDE: ELGAPDVGHPMS [SEQ ID NO: 405] PEPTIDE: ELGAPDVGHPMSEVFR [SEQ ID NO: 406] PEPTIDE: ELGAPDVGHPMSEV [SEQ ID NO: 407] PEPTIDE: ELGAPDVGHPMSE [SEQ ID NO: 408] PEPTIDE: LGAPDVGHPMSE [SEQ ID NO: 409] PEPTIDE: YRELGAPDVGHPMSE [SEQ ID NO: 410] PEPTIDE: LGAPDVGHPMSEV [SEQ ID NO: 411] PEPTIDE: RELGAPDVGHPMSE [SEQ ID NO: 412] ADDITIONAL PEPTIDES (AND SOURCE PROTEIN) HPRPPKPDAPR [SEQ ID NO: 452]-Q0D9DO LQQAPPPPQR [SEQ ID NO: 453]-Q6AVS5 VGWGEQPWSPY [SEQ ID NO: 454]-Q8H920 FHMPP [SEQ ID NO: 455]-O49927 FRRP [SEQ ID NO: 456]-P29835 FWM [SEQ ID NO: 457]-P15838 HMPPS [SEQ ID NO: 458]-049927 PVEMPTLLYPS [SEQ ID NO: 459] HMPSS [SEQ ID NO: 460]-O49927 HRFR [SEQ ID NO: 461]-Q712V4 HRRS [SEQ ID NO: 462]-P13918 HSPR [SEQ ID NO: 463]-P14323 HWF [SEQ ID NO: 464-P14323 MFRR [SEQ ID NO: 465]-Q41000 MFRRP [SEQ ID NO: 466-P29835 MPPS [SEQ ID NO: 467]-049927 MPRR [SEQ ID NO: 468]-P15838 NMPS [SEQ ID NO: 469]-P20698 PHMP [SEQ ID NO: 470]-O49927 PHMPS [SEQ ID NO: 471-O49927 PRRF [SEQ ID NO: 472]-P15838 WMK [SEQ ID NO: 473]-O04434 DSINALEPDHR [SEQ ID NO: 474]-P05692 ELTFPGSVQ [SEQ ID NO: 475]-Q9M3X6 ELTFPGSVQE [SEQ ID NO: 476]-Q9M3X6 IFEDAITIPGR [SEQ ID NO: 477]-P09886 LDALEPDNRIESE [SEQ ID NO: 478]-P02857 KTLDYWPSLR [SEQ ID NO: 479]-P08688 RHGEWGPSY [SEQ ID NO: 480] ILVDGSHDIER [SEQ ID NO: 481]-Q5N725 LVSHPIAAHEGR [SEQ ID NO: 482]-P14614 NLAQAPAQALL [SEQ ID NO: 483]-Q0DJ38 FLPQHTD [SEQ ID NO: 484]-P13918 LEPDNR [SEQ ID NO: 485]-P15838 LQSQND [SEQ ID NO: 486]-P14323 LQSQNDQRGEI [SEQ ID NO: 487]-P14323 QSQNDQRGEIIHVK [SEQ ID NO: 488]-P14323 RGEIIHVK [SEQ ID NO: 489]-P14323 RLQSQNDQ [SEQ ID NO: 490]-P14323 RLQSQNDQRG [SEQ ID NO: 491]-P14323 RLQSQNDQRGEIIH [SEQ ID NO: 492]-P14323 VFDGVLRPG [SEQ ID NO: 493]-P14323 HNPR [SEQ ID NO: 494]-P14614 HPMS [SEQ ID NO: 495]-Q0D7S0 HPSF [SEQ ID NO: 496]-Q0DEV5 MPMP [SEQ ID NO: 497]-P29835 PMPL [SEQ ID NO: 498]-P29835 PNSM [SEQ ID NO: 499]-P07728 WDP [SEQ ID NO: 500]-B5A8N6 LRGFSK [SEQ ID NO: 501]-Q9M3X6 RSQNIF [SEQ ID NO: 502]-P07728 YLRGFS [SEQ ID NO: 503]-Q9M3X6 GALMLPHYN [SEQ ID NO: 504]-Q9M3X6 GALMLPHYNSR [SEQ ID NO: 505]-Q9M3X6 KNPQLQDLDIFVNYVEIK [SEQ ID NO: 700]P02855 PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 701]P13918 RGPQQYAEWQINEK [SEQ ID NO: 702]Q6K7K6 VLDLAIPVNRPGQL [SEQ ID NO: 703]Q6K508 GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID NO: 704]P09918 LDVTPLSLGL [SEQ ID NO: 717] EEGIQLVAEAIR [SEQ ID NO: 718] YSLKPLVPR [SEQ ID NO: 719] WHT [SEQ ID NO: 720] WHN [SEQ ID NO: 721] NNPF [SEQ ID NO: 722] MRFR [SEQ ID NO: 723] MPPSS [SEQ ID NO: 724] HMPS [SEQ ID NO: 725] HMPPS [SEQ ID NO: 726] GHPM [SEQ ID NO: 727] FWN [SEQ ID NO: 728] FHMP [SEQ ID NO: 729] WTIVQGLPIDE [SEQ ID NO: 730] GYPMYPLPR [SEQ ID NO: 731] HGGEGGRPY [SEQ ID NO: 732] LRGFSK [SEQ ID NO: 733] GALMLPHYN [SEQ ID NO: 734] GALMLPHYNSR [SEQ ID NO: 735] VFDGVLRPG [SEQ ID NO: 736] LQSQND [SEQ ID NO: 737] LQSQNDQRGEI [SEQ ID NO: 738] QSQNDQRGEIIHVK [SEQ ID NO: 739] RGEIIHVK [SEQ ID NO: 740] RLQSQNDQ [SEQ ID NO: 741] RLQSQNDQRG [SEQ ID NO: 742] RLQSQNDQRGEIIH [SEQ ID NO: 743] MPMP [SEQ ID NO: 744] PMPL [SEQ ID NO: 745] LEPDNR [SEQ ID NO: 746] GIARLAGTSSVIN [SEQ ID NO: 747] RSQNIF [SEQ ID NO: 748] PNSM [SEQ ID NO: 749] GHPM [SEQ ID NO: 750] HPMS [SEQ ID NO: 751] FLPQHTD [SEQ ID NO: 752] EWQINEK [SEQ ID NO: 753] GPQQYAEWQINEK [SEQ ID NO: 754] PQQYAEWQ [SEQ ID NO: 755] RGPQQYA [SEQ ID NO: 756] HNPR [SEQ ID NO: 757] WHN [SEQ ID NO: 758] WDP [SEQ ID NO: 759] HPSF [SEQ ID NO: 760] PGQLQSFLLSGNQNQQNYLSGF [SEQ ID NO: 761] QLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 762] QSFLLSGNQNQQ [SEQ ID NO: 763] PGQLQSFLLSGN [SEQ ID NO: 764] QSFLLSGNQ [SEQ ID NO: 765] QNQQNYLSGFSK [SEQ ID NO: 766] YLRGFS [SEQ ID NO: 767] PVEMPTLLYPS [SEQ ID NO: 768] RGPQQYAEWQINE [SEQ ID NO: 769] GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID NO: 770] KNPQLQDLDIFVNYVEIK [SEQ ID NO: 771] PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID NO: 772] RGPQQYAEWQINEK [SEQ ID NO: 773] VLDLAIPVNRPGQL [SEQ ID NO: 774] RGPQQYAEWQINEK [SEQ ID NO: 775] PROTEIN P02855 [SEQ ID NOs: 546-552] PEPTIDE: SRAIVIVTVNE [SEQ ID NO: 546] PEPTIDE: AKLTPGDV [SEQ ID NO: 547] PEPTIDE: IVIVTVNEGK [SEQ ID NO: 548] PEPTIDE: LDALEPDNRIESEGGL [SEQ ID NO: 549] (also in P02857) PEPTIDE: RPYYSNAPQE [SEQ ID NO: 550] (also in P02857) PEPTIDE: LDALEPDNRIESEGGLIETWNPNNK [SEQ ID NO: 551] (also in P02857) PEPTIDE: AIVIVTVNEGK [SEQ ID NO: 552] (also in P13918) PROTEIN P02857 [SEQ ID NOs: 553-565] PEPTIDE: LQVVNCNGNTVFDGEL [SEQ ID NO: 553] PEPTIDE: QVVNCNGNTVFDGEL [SEQ ID NO: 554] PEPTIDE: IIAVPTGIVF [SEQ ID NO: 555] PEPTIDE: GRRYRDRHQKVNRFRE [SEQ ID NO: 556] PEPTIDE: RPYYSNAPQEI [SEQ ID NO: 557] PEPTIDE: RLDALEPDNRIE [SEQ ID NO: 558] PEPTIDE: RLDALEPDNRIESE [SEQ ID NO: 559] PEPTIDE: LDALEPDNRIESEGGLIETW [SEQ ID NO: 560] PEPTIDE: LDALEPDNRIE [SEQ ID NO: 561] PEPTIDE: LDALEPDNRIESEGGLIE [SEQ ID NO: 562] PEPTIDE: LDALEPDNRIESEGGL (also in P02855) [SEQ ID NO: 563] PEPTIDE: RPYYSNAPQE (also in P02857) [SEQ ID NO: 564] PEPTIDE: LDALEPDNRIESEGGLIETWNPNNK (also in P02855) [SEQ ID NO: 565] PROTEIN P07728 [SEQ ID NOs: 566-609] PEPTIDE: VEHGLSLLQPYASLQEQEQGQVQSRER [SEQ ID NO: 566] PEPTIDE: RSQNIFSGF [SEQ ID NO: 567] PEPTIDE: GITGPTFPGCPESY [SEQ ID NO: 568] PEPTIDE: CNGS [SEQ ID NO: 569] PEPTIDE: SPREC [SEQ ID NO: 570] PEPTIDE: PREC [SEQ ID NO: 571] PEPTIDE: PRECR [SEQ ID NO: 572] PEPTIDE: CPES [SEQ ID NO: 573] PEPTIDE: SGCS [SEQ ID NO: 574] PEPTIDE: CSNG [SEQ ID NO: 575] PEPTIDE: RSQNIFSGFSTE [SEQ ID NO: 576] PEPTIDE: VEEWSQNIFSGFST [SEQ ID NO: 577] PEPTIDE: WSQNIFSGFSTEL [SEQ ID NO: 578] PEPTIDE: WSQNIFSGFSTE [SEQ ID NO: 579] PEPTIDE: STSQWQSSRR [SEQ ID NO: 580] PEPTIDE: NRPI [SEQ ID NO: 581] PEPTIDE: CDGS [SEQ ID NO: 582] PEPTIDE: PRGC [SEQ ID NO: 583] PEPTIDE: PRGCR [SEQ ID NO: 584] PEPTIDE: RGCR [SEQ ID NO: 585] PEPTIDE: GCRF [SEQ ID NO: 586] PEPTIDE: PTFP [SEQ ID NO: 587] PEPTIDE: PGCPE [SEQ ID NO: 588] PEPTIDE: GCPE [SEQ ID NO: 589] PEPTIDE: CPET [SEQ ID NO: 590] PEPTIDE: AHWC [SEQ ID NO: 591] PEPTIDE: HWCY [SEQ ID NO: 592] PEPTIDE: SGCP [SEQ ID NO: 593] PEPTIDE: SGCPN [SEQ ID NO: 594] PEPTIDE: GCPN [SEQ ID NO: 595] PEPTIDE: CPNG [SEQ ID NO: 596] PEPTIDE: TFCTM [SEQ ID NO: 597] PEPTIDE: FCTM [SEQ ID NO: 598] PEPTIDE: FCTMR [SEQ ID NO: 599] PEPTIDE: CTMR [SEQ ID NO: 600] PEPTIDE: EGCA [SEQ ID NO: 601] PEPTIDE: SQNIFSGFSTELL [SEQ ID NO: 602] PEPTIDE: SQNIFSGFSTE [SEQ ID NO: 603] PEPTIDE: QNDQRGEIVR [SEQ ID NO: 604] PEPTIDE: SQNIFSGFSTEL [SEQ ID NO: 605] (also in P07730) PEPTIDE: QLQCQNDQRGEI [SEQ ID NO: 606] (also in P07730) PEPTIDE: LGQSTSQWQSSR [SEQ ID NO: 607] (also in P07730) PEPTIDE: QQLLGQSTSQWQSSR [SEQ ID NO: 608] (also in P07730) PEPTIDE: LLGQSTSQWQSSR [SEQ ID NO: 609] (also in P07730) PROTEIN P07730 [SEQ ID NOs: 610-619] PEPTIDE: NDQRGEIVR [SEQ ID NO: 610] PEPTIDE: GQSTSQWQSSR [SEQ ID NO: 611] PEPTIDE: STSQWQSSR [SEQ ID NO: 612] PEPTIDE: GITGPTFPGCPET [SEQ ID NO: 613] PEPTIDE: GITGPTFPGCPETY [SEQ ID NO: 614] PEPTIDE: SQNIFSGFSTEL [SEQ ID NO: 615] (also in P07728) PEPTIDE: QLQCQNDQRGEI [SEQ ID NO: 616] (also in P07728) PEPTIDE: LGQSTSQWQSSR [SEQ ID NO: 617] (also in P07728) PEPTIDE: QQLLGQSTSQWQSSR [SEQ ID NO: 618] (also in P07728) PEPTIDE: LLGQSTSQWQSSR [SEQ ID NO: 619] (also in P07728) PROTEIN P09918 [SEQ ID NOs: 620-630] PEPTIDE: IFFANQTYL [SEQ ID NO: 620] PEPTIDE: EHLEPNLEGLTVEE [SEQ ID NO: 621] PEPTIDE: IFFANQTYLPSETPAPLVHYREEELNNLRGDGTGER [SEQ ID NO: 622] PEPTIDE: IHFEWDDDMGIPGAFYIK [SEQ ID NO: 623] PEPTIDE: IFFANQTYLPSETPAPLVHYREEELNNLR [SEQ ID NO: 624] PEPTIDE: TEQALPADLIK [SEQ ID NO: 625] PEPTIDE: EHLEPNLEGLTVEEAIQNKK [SEQ ID NO: 626] PEPTIDE: ISKEHLEPNLEGLTVEEAIQNKK [SEQ ID NO: 627] PEPTIDE: LSLPHPQGDEHGAVSY [SEQ ID NO: 628] PEPTIDE: ISKEHLEPNLEGLTVEEAIQNK [SEQ ID NO: 629] PEPTIDE: EHLEPNLEGLTVEEAIQNK [SEQ ID NO: 630] PROTEIN P0C1U8 [SEQ ID NO: 631] PEPTIDE: LSTTGGNSGSPVFNEKNE [SEQ ID NO: 631] PROTEIN P13918 [SEQ ID NOs: 632-639] PEPTIDE: QSFLLSGNQNQQNYLSG [SEQ ID NO: 632] PEPTIDE: VLDLAIPVNRPGQLQS [SEQ ID NO: 633] PEPTIDE: VLDLAIPVNRPGQLQSFL [SEQ ID NO: 634] PEPTIDE: FLLSGNQNQQNYLSG [SEQ ID NO: 635] PEPTIDE: FLLSGNQNQQNYLSGFSK [SEQ ID NO: 636] PEPTIDE: DPQNPFIFKSNKFQTLFE [SEQ ID NO: 637] PEPTIDE: ELAFPGSAQEVDRILENQK [SEQ ID NO: 638] PEPTIDE: AIVIVTVNEGK (also in P02855) [SEQ ID NO: 639] PROTEIN P14323 [SEQ ID NOs: 640-667] PEPTIDE: INAVAAKRLQSQNDQRGE [SEQ ID NO: 640] PEPTIDE: NRAQQQQVYGSSIE [SEQ ID NO: 641] PEPTIDE: PSTNPWHSPR [SEQ ID NO: 642] PEPTIDE: CHGS [SEQ ID NO: 643] PEPTIDE: CHGSM [SEQ ID NO: 644] PEPTIDE: PWHS [SEQ ID NO: 645] PEPTIDE: FREC [SEQ ID NO: 646] PEPTIDE: RECR [SEQ ID NO: 647] PEPTIDE: ECRF [SEQ ID NO: 648] PEPTIDE: CRFD [SEQ ID NO: 649] PEPTIDE: CRFDR [SEQ ID NO: 650] PEPTIDE: CTGT [SEQ ID NO: 651] PEPTIDE: FPGC [SEQ ID NO: 652] PEPTIDE: FPGCP [SEQ ID NO: 653] PEPTIDE: PGCP [SEQ ID NO: 654] PEPTIDE: PGCPA [SEQ ID NO: 655] PEPTIDE: PGCPAT [SEQ ID NO: 656] PEPTIDE: GCPA [SEQ ID NO: 657] PEPTIDE: CPAT [SEQ ID NO: 658] PEPTIDE: ENFC [SEQ ID NO: 659] PEPTIDE: NFCT [SEQ ID NO: 660] PEPTIDE: NFCTI [SEQ ID NO: 661] PEPTIDE: FCTI [SEQ ID NO: 662] PEPTIDE: AQQQQVYGSSIEQH [SEQ ID NO: 663] PEPTIDE: AQQQQVYGSSIEQHSGQNIFSGF [SEQ ID NO: 664] PEPTIDE: AAKRLQSQNDQRGE [SEQ ID NO: 665] PEPTIDE: QARSLKNNRGEE [SEQ ID NO: 666] (also in P14614) PEPTIDE: FNPSTNPWHSPRQGS [SEQ ID NO: 667] (also in Q0DEV5) PROTEIN P14614 [SEQ ID NO: 668] PEPTIDE: QARSLKNNRGEE (also in P14323) [SEQ ID NO: 668] PROTEIN Q0D7S0 [SEQ ID NO: 669] PEPTIDE: AAASLPAFCNVDIPNGGGGVCYWLAR [SEQ ID NO: 669] PROTEIN Q0DEV5 [SEQ ID NOs: 670-680] PEPTIDE: VAGSAPGIEGDEIAPLAK [SEQ ID NO: 670] PEPTIDE: LGVAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 671] PEPTIDE: GSAPGIEGDEIAPLAKE [SEQ ID NO: 672] PEPTIDE: VAGSAPGIEGDEIAP [SEQ ID NO: 673] PEPTIDE: GVAGSAPGIEGDEIAPLAK [SEQ ID NO: 674] PEPTIDE: GVAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 675] PEPTIDE: VAGSAPGIEGDEIAPLAKEN [SEQ ID NO: 676] PEPTIDE: SAPGIEGDEIAPLAK [SEQ ID NO: 677] PEPTIDE: GSAPGIEGDEIAPLAK [SEQ ID NO: 678] PEPTIDE: SAPGIEGDEIAPLAKEN [SEQ ID NO: 679] PEPTIDE: FNPSTNPWHSPRQGS [SEQ ID NO: 680] (also in P14323) PROTEIN Q9M3X6 [SEQ ID NOs: 681-699] PEPTIDE: VDLVIPVNGPGK [SEQ ID NO: 681] PEPTIDE: LVDLVIPVNGPGK [SEQ ID NO: 682] PEPTIDE: IKLPAGTTSY [SEQ ID NO: 683] PEPTIDE: IKLPAGTTSYL [SEQ ID NO: 684] PEPTIDE: RRNPFLFKSNKF [SEQ ID NO: 685] PEPTIDE: IENPVKELTFPGSVQEINR [SEQ ID NO: 686] PEPTIDE: RRNPFLFKSNKFLT [SEQ ID NO: 687] PEPTIDE: AKPHTIFLPQHIDA [SEQ ID NO: 688] PEPTIDE: AKPHTIFLPQHIDAD [SEQ ID NO: 689] PEPTIDE: KQKYRYQRE [SEQ ID NO: 690] PEPTIDE: KQKYQYQRE [SEQ ID NO: 691] PEPTIDE: MLPH [SEQ ID NO: 692] PEPTIDE: RRNPFLFKSNKFLTLFENE [SEQ ID NO: 693] PEPTIDE: PFLFKSNKFLTLFE [SEQ ID NO: 694] PEPTIDE: SQERRNPFLFKSNKFLTLFE [SEQ ID NO: 695] PEPTIDE: RRNPFLFKSNKFLTLFE [SEQ ID NO: 696] PEPTIDE: SQERRNPFLFKSNKFLTLFENE [SEQ ID NO: 697] PEPTIDE: LTFPGSVQE [SEQ ID NO: 698] PEPTIDE: ELTFPGSVQEINR [SEQ ID NO: 699] Rice Protein: Q0D9D0 MLCLTSSSSSAPAPLLPSLADRPSPGIAGGGGNVRLSVVSSPRRSWPGKVKTNFSVPATA RKNKTMVTVVEEVDHLPIYDLDPKLEEFKDHFNYRIKRYLDQKCLIEKHEGGLEEFSKGY LKFGINTVDGATIYREWAPAAQEAQLIGEFNNWNGAKHKMEKDKFGIWSIKISHVNGKPA IPHNSKVKFRFRHGGGAWVDRIPAWIRYATFDASKFGAPYDGVHWDPPACERYVFKHPRP PKPDAPRIYEAHVGMSGEEPEVSTYREFADNVLPRIRANNYNTVQLMAIMEHSYYASFGY HVTNFFAVSSRSGTPEDLKYLVDKAHSLGLRVLMDVVHSHASNNVTDGLNGYDVGQNTHE SYFHTGDRGYHKLWDSRLFNYANWEVLRFLLSNLRYWMDEFMFDGFRFDGVTSMLYHHHG INKGFTGNYKEYFSLDTDVDAIVYMMLANHLMHKLLPEATIVAEDVSGMPVLCRPVDEGG VGFDFRLAMAIPDRWIDYLKNKEDRKWSMSEIVQTLTNRRYTEKCIAYAESHDQSIVGDK TIAFLLMDKEMYTGMSDLQPASPTINRGIALQKMIHFITMALGGDGYLNFMGNEFGHPEW IDFPREGNNWSYDKCRRQWSLVDTDHLRYKYMNAFDQAMNALEEEFSFLSSSKQIVSDMN EKDKVIVFERGDLVFVFNFHPNKTYKGYKVGCDLPGKYRVALDSDALVFGGHGRVGHDVD HFTSPEGMPGVPETNFNNRPNSFKVLSPPRTCVAYYRVDEDREELRRGGAVASGKIVTEY IDVEATSGETISGGWKGSEKDDCGKKGMKFVFRSSDEDCK [SEQ ID NO: 705] Rice protein: Q6AVS5 MDRYQRVERPRPESAIEENEIRITAQGLIRNYVSYATSLLQDRRIKEIVLKAMGQAISKS VAVAEIIKKRVPGLYQDTNISSVSITDVWEPIEEGLVPLEMTRHVSMISITLSPRDLDKN SPGYQTPVYVEQPRQQPRLQQAPPPPQRQVRQPPPDYEDSYVRGRGRGRGRGRGRGWGRG GYGGYGGYGNNQGGYNQGGGYYDNQGGYGGYDNQGGYGGYDNQGGYGGGGYGYNQGRYGN YQENGGYNRGRGGMRGRGNWNYRGGYERGRGGGFPGGRGYGGRGRGRMGGRGGRGN [SEQ ID NO: 706] Rice Protein: Q8H920 MALEHLGRRNVAGSLLLLNLLMYVFLLGFAGWALNSSIKNAGADVGVGWGEQPWSPYYRQ SAWFASRFHLATFAALAGALGVAAKASAAYHGGRSGASWRPQGLAAAASLGTAAWAATAL AFGVACREIHDAAAAGPAGAARGWRMRALEGLTVTLAFTQLLYVLLLHAAVAGERCGLAC AADA [SEQ ID NO: 707] Pea protein: O49927 MAIKTKLSLTIFLFFLLALLCSNLAVGRKEKDPELTTCKDQCDMQRQYDEEDKRICMERC DDYIKKKQERQKHKEHEEEEEQEQEEDENPYVFEDNDFETKIDTKDGRVLILNKFNEKSK LLKNIENYGLAVLEIKANAFLSPHHYDSEAILFNIKGRGIIGLVAEDRTERFNLEEGDIM RVPAGTPMYLVNRDENEKLYIAAFHMPPSSGSAPVNLEPFFESAGRKPESVLNTFSSKVL QAALKSSKGELETVLDEQKKGRIFKIEKEDVRGLAPKKSLWPFGGPFKSPFNIFSNNPAF SNKFGSLFEVGPSQEKSGLEGLNLMLTLANITKGSMSTIHYNTNANKIALVIDGEGELEM ACPHMPSSSSNSRQKKSSISYHNINAKLRPGVMFVVPAGHPFVNIASKKKNLIVVCFEVN AQRNKKLALAGKKNIVSALDKAAKEVAFDIAAEKVDEVFERKEEFFFPYDNEERKEEHGR AVV [SEQ ID NO: 708] Pea protein: Q41000 MFRRATSTFLSRASATRRFSTDVATPATNSSFVEAWRKVSPNIDPPKTPLEFLKTRPPVP STIPTKLTVNFVLPYSSQLAAKEVDSVIIPATTGEMGVLPGHVATIAELKPGVLTVQEGT DTTKYFVSSGFRFIHANSVADIIAVEAVPVNQLDRDLVQKGLQEFTQKLNSATTDLEKRE AQIGIDVDSALNSALTG [SEQ ID NO: 709] Rice Protein: P20698 MKIIFFFALLAIAACSASAQFDAVTQVYRQYQLQPHLMLQQQMLSPCGEFVRQQCSTVAT PFFQSPVFQLRNCQVMQQQCCQQLRMIAQQSHCQAISSVQAIVQQLRLQQFASVYFDQSQ AQAQAMLALNMPSICGIYPSYNTAPCSIPTVGGIWY [SEQ ID NO: 710] Pea Protein: O04434 MQDSSTMKFSPLDLMTAIIKGKFNPSNDSSQAPASIIFENREFVMILTTSIAVLIGCVVV LIWRRSNSNKSKQIEVPKLVIKKLPELDVDDGKKKVTVFFGTQTGTAEGFAKAIAEEAKA RYEKAKFRVVDMDDYAADDDEYLEKLKRETMALFFLATYGDGEPTDNAARFYKWFTEEYE GEEDSFKNLSYGVFGLGNRQYEHFNKVAKVVDDKLLEQGGKRLVPVGLGDDDQCIEDDFT AWKEELWPALDQLLRDEDDTPVATPYTAAVSEYRVVIHDPLDATVDEKKRHNVNGHAVVD AQHPVRANVAVRRELHTPASDRSCTHLEFDISGTGVVYETGDHVGVYCENLSDTVEEAER ILGLSPDTYLSIHTDDEEGKPLGGSSLPPPFPPCTLRTALTKYADLLSSPKKSALVALAA HASDPSEADRLRHLASPAGKDEYAEWVISSQRSLLEVMAEFSSAKPPIGVFFAAVAPRLQ PRYYSISSSPRMAPSRIHVTCALVHDKMPTGRIHKGVCSTWMKNSVPLEKNQDCSWAPIF VRQSNFRLPADNKVPVIMIGPGTGLAPFRGFLQERLALKEDGAELGPSVLFFGCRNRQVD YIYEDELNHFVNGGALSELIVAFSRDGPTKEYVQHKMMEKASDIWNMISQGAYVYVCGDA KGMARDVHRTLHTILQEQGSLDSSKTESMVKNLQMTGRYLRDVW [SEQ ID NO: 711] Rice Protein: Q5N725 MSAYCGKYKDELIKNAAYIGTPGKGILAADESTGTIGKRFASINVENVEENRRSLRELLF TTPGALQHLSGVILFEETLYQKTKDGKPFVDVLKEGGVLPGIKVDKGTVEVAGTNKETTT QGHDDLGKRCAKYYEAGARFAKWRAVLKIGPNEPSQLSIDLNAQGLARYAIICQENGLVP IVEPEILVDGSHDIERCAYVTEKVLAACYKALNEHHVLLEGSLLKPNMVTPGSESKKVSP QLIAEYTVRALQRTVPAAVPAIVFLSGGQSEEEATVNLNAMNKLSTKKPWALSFSFGRAL QQSTLKAWGGKTENVVKAQKAFITRCKANSEATLGTYQGDAVLGEGASESLHVKDYKY [SEQ ID NO: 712] Pea Protein: B5A8N6 MASLQTQMISFYAIFLSILLTTILFFKVNSTETTSFLITKFSPDQQNLIFQGDGYTTKEK LTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV DTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK SWKLQNGEEANVVIAFNAATNVLTVSLTYPNSLEEENVTSYTLSDVVSLKDVVPEWVRIG FSATTGAEYAAHEVLSWSFHSELSGTSSSKQAADA [SEQ ID NO: 713] Rice Protein: Q6K508 MATTTSLLSSCLCALLLAPLFSQGVDAWESRQGASRQCRFDRLQAFEPLRKVRSEAGDTE YFDERNEQFRCAGVFVIRRVIEPQGLVVPRYSNTPALAYIIQGKGYVGLTFPGCPATHQQ QFQLFEQRQSDQAHKFRDEHQKIHEFRQGDVVALPASVAHWFYNGGDTPAVVVYVYDIKS FANQLEPRQKEFLLAGNNQRGQQIFEHSIFQHSGQNIFSGFNTEVLSEALGINTEASKRL QSQNDQRGDIIRVKHGLQLLKPTLTQRQEEHRQYQQVQYREGQYNGLDENFCTIKARVNI ENPSRADYYNPRAGRITLLNNQKFPILNLIGMGAARVNLYQNALLSPFWNINAHSVVYII QGSVRVQVANNQGRSVFNGVLHQGQLLIIPQNHAVIKKAEHNGCQYVAIKTISDPTVSWV AGKNSILRALPVDVIANAYRISRDEARRLKNNRADEIGPFTPRFPQKSQRGYQFLTEGLS LIGM [SEQ ID NO: 714] PEA PROTEIN: Q712V4 QKAPRKQLATKAARKSAPATGGVKKPHRFRPGTVALREIRKYQKSTELLIRKLPFQRLVR EIAQDFKTDLRFQSSAVSALQEAAEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRG ERA [SEQ ID NO: 715] Pea Protein: P09886 MAQSVSLSTIASPILSQKPGSSVKSTPPCMASFPLRRQLPRLGLRNVRAQAGGDGDNKDN SVEVHRVNKDDQGTAVERKPRRSSIDISPFGLLDPWSPMRSMRQMLDTMDRIFEDAITIP GRNIGGGEIRVPWEIKDEEHEIRMRFDMPGVSKEDVKVSVEDDVLVIKSDHREENGGEDC WSRKSYSCYDTRLKLPDNCEKEKVKAELKDGVLYITIPKTKIERTVIDVQ1Q [SEQ ID NO: 716] Examples of homologs for each protein P13918 (Pea) >gi|137584|sp|P08438.1| VCL_VICFA RecNa me: Full = Vicilin; Flags: Precursor [Vicia faba] >gi|22057|emb|CAA68559.1| vicilin [Vicia faba var. minor] >gi|383931031|gb|AFH56916.1| vicilin [Vicia faba] MAATTLKDSFPLLTLLGIAFLASVCLSSRSDQDNPFVFESNRFQTLFENENGHIRLLQKFDQHSKLLENLQNYRLLEYKSKPHTIFLPQQTDADFIL VVLSGKAILTVLLPNDRNSFSLERGDTIKLPAGTIGYLVNRDDEEDLRVLDLVIPVNRPGEPQSFLLSGNQNQPSILSGFSKNILEASFNTDYKEIEK VLLEEHGKEKYHRRGLKDRRQRGQEENVIVKISRKQIEELNKNAKSSSKKSTSSESEPFNLRSREPIYSNKFGKFFEITPKRNPQLQDLNIFVNYVEI NEGSLLLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEYDEEKEQGEEEIRKQVQNYKAKLSPGDVLVIPAGYPVAIKASSNLNLVGFGI NAENNQRYFLAGEEDNVISQIHKPVKELAFPGSAQEVDTLLENQKQSHFANAQPRERERGSQEIKDHLYSILGSF [SEQ ID NO: 506] >gi|502105533|ref|XP_004492829.1| PREDICTED: vicilin-like isoform X1 [Cicer arietinum] ChickPea MAIKARFPLLVLLGIVFLASVCAKSDKENPFFFKSNNCQTLFENENGHVRLLQRFDKRSQLFENLQNYRLMEYNSKPHTLFLPQHNDADFILVVL RGRAILTVLNPNDRNTFKLERGDTIKLPAGTIAYLANRDDNEDLRVLDLAIPVNRPGQFQSFSLSGNENQQSYFQGFSKKILEASFNSDYEEIERV LLEEQEQKPEQRRGHKGRQQSQETDVIVKISREQIEELSKNAKSNCKKSVSSESEPFNLRSRSPIYSNRFGNFFEITPEKNPQLKDLDIFVNSVEIK EGSLLLPHFNSRATVILVVNEGKGEVELVGLRNENEQENKKEDEEEEEDRNVQVQRFQSKLSSGDVVVIPASHPFSINASSDLFLLGFGINAQN NQRNFLAGEEDNVISQIQRPVKEVAFPGSAEEVDRLLKNQRQSHFANAQPQQKRKGSQRIRSPF [SEQ ID NO: 507] >gi|29539109|emb|CAD87730.1| allergen Len c 1.0101 [Lens culinaris] Lentil SRSDQENPFIFKSNRFQTIYENENGH1RLLQRFDKRSKIFENLQNYRLLEYKSKPHTIFLPQFTDADFILVVLSGKAILTVLNSNDRNSFNLERGDTI KLPAGTIAYLANRDDNEDLRVLDLAIPVNRPGQLQSFLLSGTQNQPSFLSGFSKNILEAAFNTEYEElEKVLLEEQEQKSQHRRSLRDKRQEITNE DVIVKVSREQIEELSKNAKSSSKKSVSSESEPFNLRSRNPIYSNKFGKFFEITPEKNPQLQDLDIFVNSVEIKEGSLLLPNYNSRAIVIVTVNEGKGDF ELVGQRNENQQEQREENDEEEGQEEETTKQVQRYRARLSPGDVLVIPAGHPVAINASSDLNLIGFG1NAKNNQRNFLAGEEDNVISQIQRPV KELAFPGSSREVDRLLTNQKQSHFANAQPLQIE [SEQ ID NO: 508] Q9M3X6 (Pea) >gi|164512526|emb|CAP06312.1| cvc [Pisum abyssinicum] MATTVESRFPLLLFPGIIFLASVCVTYANYDEGSETRVPGQRERGRQEGEKEEKRHGEWRPSYEKEEDEEEKQKYRYQREKEDEEEKQKYRYQR EKKEEKEVQPGRERWEREEDEEQVDEEWRGSQRRQDPEERARLRHREERTKRDRRHKREGEEEERSSESQEQRNPFLFKSNKFLTLFENENG HIRRLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQH1DADLILVVLNGKAILTVLSPNDRNSYNLERGDTIKIPAGTTSYLVNQDDEEDLRVVD FVIPVNRPGKFEAFGLSENKNQYLRGFSKNILEASLNTKYETIEKVLLEEQEKKPQQLRDRKRRQQGGERDAIIKVSREQIEELRKLAKSSSKKSLPS EFEPFNLRSHKPEYSNKFGKLFEITPEKKYPQLQDLDILVSCVEINKGALMLPHYNSRAIVVLLVNEGKGNLELLGLKNEQQEREDRKERNNEVQ RYEARLSPGDVVIIPAGHPVAISASSNLNLLGFGTNAENNQRNFLSGSDDN [SEQ ID NO: 509] >gi|164512538|emb|CAP06318.1| cvc [Lathyrus annuus] MATTIKSRFPLLLLLGIIFLASVCVTWANYDEGSEPRVPGQRERGRQEGEKEEKRHGEWRPSYEEEYDEGLEPKVPGKRERGRQEGEKEEKRHE EWRPSYEKEEDEEEKQKYNYQREKKEHKEVQPGRERWERKQDEKQVEEDEEPGEEQWRGSKRHEDPEERARLRHREEKTKSYVEDNEETSS KEGRNPFLFKSNKFLTLFENENGHIRRLQRFDERSDIFENLQNYRLVEYRAKPHTMFLPQHIDADLILVVLNGKAILTVLSPNDRNSYNLERGDTV KLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKFEAFGLSANKNQYLRGFSKNILEASLNTKYETIEKVLLEERRDQKGRQQGQETNAIVKVSRE QIEELRKLAKSSSKKSLLSESEPLNLRSQNPKYSNKFGKFFEITPQKKYPQLQDLDVSISCVEINKGALLLPHYNSRSIGILLVNEGKGNLELVGFKNE QQRQRENEETNKKLQRYEARLSSGDVVVIPEGHPVAISASSNLNLLGFGINAANNQRNFLTGSDDN [SEQ ID NO: 510] >gi11645125581embICAP06328.11 cvc [Vicia villosa] MA-MKSRFPVLLLLGIIFLTSVCVTYANYDEGREPSVPGQRERGRQEGEKEEKRHGEWRPSEEDEEEKYKYEEGRVPGQRERGRQEGEKEEKR HGKWRPSEEEDEEEKYRYEEGSEPRGPGQRETGRQEGEKEKQRPEREPSYEKEEDEEEKQKYQYHREKKEQREVRPGRERFERHEDEEQWRG IQRHEDPEERARERYRAEIAKRQVEEEREERDIPHEREQRNPFLFKSNKFQTLFQNENGYIRRLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQ HIDADLIIVVLSGRAILTVLSPDDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKVESFLLSGNKNQYLRGFSKNILEASFNT NYETIERVLLEEQDKESQQSIGQKRRSQRQETNALVKVSREQLEDLKRLAKSSSQEGLSSQFEPINLRSQNPKYSNKFGKVFEITPEKKYPQLQDL DLFVSSVDIKEGALMLPHYNSRAIVVLLVNEGRGNLELVGLKNEQQEQREKEDEQQERNNQVQRYEARLSPGDVVIIPAGHPVAVRASSDLNL LAFGINAENNQRNFLAGSDDN [SEQ ID NO: 511] P09918 (Pea) >gi|357454557|ref|XP_003597559.1| Seed lipoxygenase-3 [Medicago truncatula] >gi|355486607|gb|AES67810.1| seed linoleate 95-lipoxygenase [Medicago truncatula] MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTSVGGVIGQGFDILGSTLDNLTAFLGRSVSLQLISATKPDANGKGKLGKATFLEGIITSLPTLG AGQSAFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIYFVCNSWIYNAKHHKLDRIFFANKAYLPSETPAPLVHYREEELNNLR GDGTGERKEWERIYDYDVYNDLGNPEKGDNHARPVLGGSDTYPYPRRGRTGRKPNPKDPKSESRSDFVYLPRDEAFGHLKSSDFLTYGLKAVS QNVVPALESVIFDLNFTPNEFDSFDEVHGLYEGGIKLPTDVLSKISPLPVLKEIFRTDGEQFLKYPPPKVLQVSRSAWMTDEEFAREMLAGVNPN VICCLQEFPPRSKLDSQVYGDHTSKITKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTPTKAYATRTILFLSSDKTLKPLAIELSLPHP DGDEHGAVSHVYQPALEGVESTIWLLAKAYVVVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSYLHPIYKLLYPHYRDTMNINSLARQSLVN DGGIIEKTFLWGRYSMEMSSKVYKNWTLPGQALPADLIKRGMAIEEPSSPCGVKLVVEDYPYAHDGLEIWAAIKTWVQDYVSLYYTTDDILRQ DSELQAWWKELVEVGHGDKKNEPWWPKMQAREELVEVCTTVIWIASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEYNELVKSPQ KAYLKTITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKKFGNKLAEIEKNLAQRNNDEKLRHRLGPVQMPYTLLHPSSEEGL TFRGI PNSISI [SEQ ID NO: 512] >gi|734403888|gb|KHN32710.1| Seed linoleate 95-lipoxygenase-3 [Glycine soja] MLGGLLHRGHKIKGTVVLMRKNVLDVNSVTSVGGIIGQGLDLVGSTLDTLTAFLGRSVSLQLISATKADANGKGKLGKATFLEGIITSLPTLGAG QSAFKINFEWDDGSGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIHFVCNSWIYNAKLFKSDRIFFANQTYLPSETPAPLVKYREEELHNLRGDG TGERKEWERIYDYDVYNDLGDPDKGENHARPVLGGNDTFPYPRRGRTGRKPTRKDPNSESRSNDVYLPRDEAFGHLKSSDFLTYGLKSVSQN VLPLLQSAFDLNFTPREFDSFDEVHGLYSGGIKLPTDIISKISPLPVLKEIFRTDGEQALKFPPPKVIQVSKSAWMTDEEFAREMLAGVNPNLIRCL KDFPPRSKLDSQVYGDHTSQITKEHLEPNLEGLTVDEAIQNKRLFLLDHHDPIMPYLRRINATSTKAYATRTILFLKNDGTLRPLAIELSLPHPQGD QSGAFSQVFLPADEGVESSIWLLAKAYVVVNDSCYHQLVSHWLNTHAVVEPFIIATNRHLSVVHPIYKLLHPHYRDTMNINGLARLSLVNDGG VIEQTFLWGRYSVEMSAVVYKDWVFTDQALPADLIKRGMAIEDPSCPHGIRLVIEDYPYAVDGLEIWDAIKTWVHEYVFLYYKSDDTLREDPEL QACWKELVEVGHGDKKNEPWWPKMQTREELVESCAIIIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEKGSAEYEELRKNPQKAYLKT ITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKRFGNKLAQIENKLSERNNDEKLRNRCGPVQMPYTLLLPSSKEGLTFRGIP NSISI [SEQ ID NO: 513] >gi|593700103|ref|XP_007150490.1| hypothetical protein PHAVU_005G 157000g [Phaseolus vulgaris] >gi|561023754|gb|ESW22484.1| hypothetical protein PHAVU_005G157000g [Phaseolus vulgaris] MFSGVSGLINRGHKLKGTVVLMRKNVLDVNSVTSVGGIVGQGLDILGSTVDNLTAFLGRSVSLQLISATKPDANGKGKLGKATFLEGIITSLPTL GAGQSAFKIHFEWDDEMGIPGAFYIKNFMQTEFYLVSLTLEDIPNHGSLHFLCNSWIYNAKHFKNDRIFFVNQIYLPSETPAPLVKYREEELVN MRGDGTGERKEWDRIYDYDVYNDLGDPDKGENNARPILGGSDTLPYPRRGRTGRRPTRKDPKSESRSSDIYLPRDEAFGHLKSSDFLTYGLKS VSQNFLPALQSAFDLNFTPNEFDSFEEVHGLYSGGIKLPTDVLSKISPLPVLKEIFRTDGEQTLKFPPPKVVQDSKSAWMTDEEFAREMICGVNP NLIRLLQDFPPQSKLDSQVYGDHTSQITKENLEPNLEGLTVDEAIQSKRLFLLDHHDSIMPYLRRINATSSKAYATRTILFLKKDRTLKPLAIELSLP HPGGDKSGVVSQVFLPADEGVESSVWLLAKSYVIVNDSSYHQLVSHWLNTHAVVEPFVIATNRHLSVVHPIYKLLHPHYRDTMNINALARGD LVNHGGIIEKTFVWGRYSMEMSAVIYKDWVFTDQALPADLIKRGIATEDPECPHGLRLFIEDYPYAVDGLEIWDAIKTWVHEYVFLYYKSDDTL KEDPELQAWWKELVEVGHGDKKNEPWWPKMQTREELVEACSIVIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEEGSAEYEELKKSP QKALLKTITPKFQTLVDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKRFGKKLSEIEKKLSQRNNDEKLRNRYGPVMMPYTLLFPSSDE GLTFRGIPNSISI [SEQ ID NO: 514] P02857 (Pea) >gi|483449|emb|CAA83677.1| legumin A [Vicia sativa] MAKLLALSLSFCFLLFSSCFALREQSQQNECQLERINALEPDNRIESEGGLIETWNPNNRQFRCARVALSRATLQRNALRRPYYSNAPQEIYIQQ GNGYFGMVFPGCPETHEEPQQSEQGEGRRYRDSHQKVNRFREGDIIAVPTGIAFWMYNDQDTPVIAISLTDTGSSNNQLDQMPRRFYLAG NQEQEFLRYQHQQGGKQEQDNDGNNIFSGFKRDFLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIIAPPERQARHERGSRQEEDED EKEERQPSHHKSRRDEDEDDKEKRHSQKGQSRRQGDNGLEETVCTAKLRANIGSSPSPDIYNPQAGRIKTVTSLDLPVLRWLKLSAEHGSLHK NAMFVPHYNLNANSVIYALKGRARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSERFTYVAFKTDDRASIARLAGTSSVIDDLPLDV VAATFNMQRNEARQLKSNNPFKFLVPPRQSEMRASA [SEQ ID NO: 515] >gi|600108|emb|CAA86824.1| legumin A precursor [Vicia narbonensis] MAKLLALSLSLCFLLFSNSFALREQSQQNECQLERLDALEPDNRIESEGGLIETWNPNNRQFRCAGVALSRVTLQRNALRRPYYSNAPQEIYIQQ GNGYFGVVFPGCPETFEEPQESEQRERRRYRDSHQKVNRFREGDIIAVPTGNVLWMYNDQDTPVIAISLTDTGSSNNQLDQIPRRFYLAGNQ EQEFLRYQREQGGKQEQENDGNNIFSGFKRDFLEDALNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIITPPERQRGSRQEEDEDEKEERQPS RRRDESQKGESRRHGDNGLEETVCTAKLRVNIGSSPSPDIYNPQAGRINTVTSLDLPVLRWLKLSAEHGSLRKNALIVPHYNRNANSVIYALKG RARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSERFTYVAFKTNDRDGIARLAGTSSVINDLPLDVVAATFNLQRNEARQLKSNNPF KLLVPPRESEKRASA [SEQ ID NO: 516] >gi|502110016|ref|XP_004493779.1| PREDICTED: legumin-like [Cicer arietinum] MAKLLALSLSFCFLLFGSCFALRDQPEQNECQLEHLNALEPDNRIKSEGGLIETWNPSNKQFRCAGVALSRATLQPNSLRRPFYTNAPQEIFIQQ GNGYFGMVFPGCVETFEEPRESEQGEGSKFRDSHQKVNRFREGDIIAVPTGVVFWMFNDQDTPVIAVSLIDTSSFQNQLDQMPRRFYLAGN HEXXXXXXXXQQEGSEEEENEGGNIFSGFKRDFLEDALNVNRRIVNKLQGRNEDEEKGAIVKVKGGLSIITPPEKEPRQKRGSRQEEDEDEDEK RQPHRHSRQDEDEDEKRQPRRHSRGGSKSQRDNGFEETICTARLHQNIGSSSSPDIYNPQAGRIKTVTSFDLPALRFLKLSAEFGSLHKNAMFV PHYNLNANSILYALKGRARLQIVNCKGNSVFDGELEAGRALIVPQNFAIAAKSLSDRFSYVAFKTNDRAAIGRLLGASSLINGMPEEVVAAAFN MERNEARQLKFNSPFSFLVPPRSDSDNKAAA [SEQ ID NO: 517] P02855 (Pea) >gi|164512536|emb|CAP06317.1| cvc [Lathyrus hirsutus] MAIIIKSRFPLLLLLGIIFLASVCATWANYDEGSEPRVPGQRERGRQEGEKAEKSHEKWRPSYEEEYDEGSEPRVPGKRERGRQEGEKEEKRHGE WRPSHEEEYDEGSEPRVPTHGERGRQEGEKEEKRHEEWRPSYEKEEDEEEKEKYKYQREKKEQKEVQPGREKWERKQDEKHVEEDEDQEEE QWRGSKRREDPEERARLRYREERTKSNVEEETEERRNPFLFKSNKFLTLFENENGHIRRLQRFDERSDIFENLQNYRLVEYKAKPHTMFLPQHID ADLIIVVLNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKFEAFGLSANKNQYLRGFSKNILEAFLNTKY ETIEKVLLEEQERRDRKGRQQGQETNAIVKVSREQIEELRKLAKSSSKKSLLSESEPINLRSQNPKYSNKFGKLFEITPEKKYPQLQDLDVSISCVEI NEGAPLLPHYNSRAIVLLLVNEGKGNLELVGFKNEQQRQRENEERNKKVQRYEARLSPGDVVVIPAGHPVAISASLNLNLVGFGVNAENNQR NFLTGSDDN [SEQ ID NO: 518] >gi|164512542|emb|CAP06320.1| cvc [Lathyrus cicera] MATIIKSRFPLLLLLGIIFLASVCVTLANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSHEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGE WRPSYEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGEWRPSYEKEYDEEEKQKYQYEREKEEQKEVQPGRERWERKEDEEKEEDQWRGSQ RHEDPEERARLRYRKERTKKYVEEDTEETSSESQGRRNPFLFKSNKFLTLFENENGYIRRLQRFDERSDIFENLQNYRLVEYRAKPHTIFLPQHIDA DLILVILNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTSYLVNEDDEEDLRVVDLVIPVNRPGKFEAFDLNQYLGGFSKSVLEASLNTKYETIEKVL LEEQQKQGQETNAIVKVSREQIEELRKLAKSSSKKSLLSELEPVNLRSHSPKYSNKFGKFFEITPEKKYPQLQDLDVSISCVEINEGALLLPHYNSRA IVVVLVNEGKGNLELLGVQNEDEQQERKERNKEVQRYEARLSPGDVVIIPSGHPVAVSASSNLNLLGFGINAENNQRNFLSGSDDN [SEQ ID NO: 519] >gi|164512544|emb|CAP06321.1| convicilin [Lathyrus sativus] MATIIKSRFPLLLLLGIIFLASVCVTYANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSSEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGE WRPSYEKEYDEEEKQKYQYEREKKEQKEVEPGRERWERKEDEEKEEDQWRGSQRHEDPEERARLRYRKERTKKYVEEDTEETSSESQGRRNP FLFKSNKFLTLFENENGYIRRLQRFDERSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLILVILNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTS YLVNEDDEEDLRVVDLVIPVNRPGKFEAFDLNQYLGGFSKSVLKASLNTKYETIEKVLLEEQQKQGQETNAIVKVSREQIEELRKLAKSSSKKSLLS ELEPVNLRSHSPKYSNKFGKFFEITPEKKYPQLQDLDVSISCVEINEGALLLPHYNSRAIVVLLVNEGKGNLELLGVQDEDEQQERKKRNKEVQRY EARLSPSDVVIIPAGHPVAVSASSNLNLLGFGINAENNERNFLSGSDDN [SEQ ID NO: 520] D3VNE1 (Pea) >gi|357507721|ref|XP_003624149.1| Provicilin [Medicago truncatula]  >gi|87162569|gb|ABD28364.1| Cupin, RmlC-type [Medicago truncatula] >gi|355499164|gb|AES80367.1| vicilin 47 kDa protein [Medicago truncatula] MAIKAPFQLLMLLGIFFLASVCVSSRDDRHDQENPFFFNANHFQTLFENENGHIRLLQRFDKRSKIFENLQNYRLLEYHSKPHTLFLPQHNDAD FlLAVLSGKAILTVLNPDNRNSFNLERGDTIKLPAGSIAYLANRDDNEDLRVLDLAIPVNRPGKFQSFSLSGSQNQQSFFSGFSKNILEAAFNANY EEIERVLIEEHEQEPQHRRGLRKDRRQQSQDSNVIVKVSREQIEELSRHAKSSSRRSGSSESAPFNLRSREPIYSNEFGNFFEITPEKNPQLKDLDIL VNYAEIREGSLLLPHFNSRATVIVVVDEGKGEFELVGQRNENQQEQREEDEQQEEERSQQVQRYRARLSPGDVYVIPAGHPTVVSASSDLSLL GFGINAENNERNFLAGEEDNVISQIERPVKEVAFPGSAQDVESLLKNQRQSYFANAQPQQREREEGRSQRQRELISSILGVF [SEQ ID NO: 521] >gi|164512560|emb|CAP06329.1| convicilin [Vicia peregrina] MATTFKSRFSLLLLLGIIFLAFVCVTCANYDEGSEPRVPGQRERGRQEGEKEEQSRERHPQREPSREKEEDEEEKQKYDEGTEPRVPGQRERGR QEGEKEEQRRERHPGQREPSQEEDEEREESDRRQEGSSKSEEQRNPFLFKSNKFLTLFQNGNGHIRLLQRFDKRSDLFENLQNYRLLEYRAKPH TIFLPQHIDADLILVVLSGRAILTVLSPDDRNSYNLERGDTIKLPAGTTSYPLNQDDEEDLRVVDLAISVNRPGKVESFNLSGNKNQYLRGFSENIL EASFNTKYETIEKVLLEEQDKESQQPRGQRLQRQETNALVKVSREQVEELKRLARTSSKKGVSSEFEPFNLRSHGPKYSNKFGKFFEITPEKKYPQ LQDLDISVSSVEINEGALFLPHYNSRAIVVVLVDEGKGNLELVGFKNEQQEQREKEDEQEERNKQVQRYEAKLSPGDVVIIPAGHPVAVSASSN LNLLGFGINAENNQRNFLTGSDDN [SEQ ID NO: 522] >gi|164512562|emb|CAP06330.1| convicilin [Vicia lutea] MATTIKLRFPLLLLLGVILLASVCVTCANYDEGSEPRVPGRPEGEKEEKHRGKLRPSYEKEEDEGEKQRYHYEKKEQKEAQPRREKKEQKEEEKQ VEEESRESQRYEDPGERARERYRAEIIKRQVEKEREERDRRHQREGEEEEGSSKSRNPFLFKSNNFLTLFENENGHIRLLQRFDKRSDLFENLQNY RLVEYRAKPHTIFLPQHIDADLILVVLSGKAILTVLSPNNRNSYNLKRGDTIKLPAGTTSYLLNSDDEEDLRMVDLAISVNRPGKVESFNLSGNKN QYLRGFSKNILEASFNTKYETIEKVLLEEQDKESQQSIGQKRISQRQETNALVKVSREQIEEPKRLARSSSRKGVSSEFEPINLRSQRPKYSNKFGKF YEISPEKKYPQLQDLDVSVSSVEINEGALLLPHYNSRAIVTVLVNEGKGNLELIGFQNEQQGQREKEDEQQHERNKQVQRYDARLSSGDVVIIP AGHPVAVSASSNLDLLGFGINAENSQRNFLTGSDDN [SEQ ID NO: 523] P07728 (Rice) >gi|531874314|gb|AGT59174.1| glutelin, partial [Oryza sativa Indica Group] CRFDRLQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSAVRRVIEPRGLLLPHYTNGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLT ESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVTDLNNGANQLDPRQRDFLLAGNKRNPQAYRREVEERSQNIFSG FSTELLSEALGVSSQVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQEQEQGQVQSRERYQEGQYQQSQYGSGCSNGLDETFCTMKVRQNI DNPNRADTYNPRAGRVTNLNTQNFPILNLVQMSAVKVNLYQNALLSPFWNINAHSVVYITQGRARVQVVNNNGKTVFNGELRRGQLLIIPQ HYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPNDVLANAYRISREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNAAESS  [SEQ ID NO: 524] >gi|109894635|gb|ABG47337.1| glutelin precursor [Zizania latifolia] MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFDRLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRG LLLPQYTNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFKDEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVA IYVIDINNAANQLDPRQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQKQEQPRERYQVTQHQQSQYGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILNLIQMSAVKVNLYQNALLSP FWNINSHSVVYVTQGCARVQVVNNNGKTVFNGELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFRALPTDVLANAY RISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID NO: 525] >gi|472867|emb|CAA52764.1| 11S globulin [Avena sativa] MATTSFPSMLFYFCIFLLFHGSMAQLFGQSSTPWQSSRQGGLRGCRFDRLQAFEPLRQVRSQAGITEYFDEQNEQFRCTGVSVIRRVIEPQGL VLPQYHNAPALVYILQGRGFTGLTFPGCPATFQQQFQPFDQSQFAQGQRQSQTIKDEHQRVQRFKQGDVVALPAGIVHWCYNDGDAPIVA IYVFDVNNNANQLEPRQKEFLLAGNNKREQQSGNNIFSGLSVQLLSEALGISQQAAQRIQSQNDQRGEIIRVSQGLQFLKPIVSQQVPGEQQV YQPIQTQEGQATQYQVGQSTQYQVGKSTPYQGGQSSQYQAGQSWDQSFNGLEENFCSLEARKNIENPQHADTYNPRAGRITRLNSKNFPIL NIVQMSATRVNLYQNAILSPFWNINAHSVIYMIQGHARVQVVNNNGQTVFNDILRRGQLLIVPQHFVVLKKAEREGCQYISFKTNPNSMVSH IAGKSSILRALPIDVLANAYRISRQEARNLKNNRGEEFGAFTPKLTQKGFQSYQDIEEGSSSPVRASE [SEQ ID NO: 526] P14614 (Rice) >gi|115445309|ref|NP_001046434.1| Os02g0248800 [Oryza sativa Japonica Group]  >gi|37993738|gb|AAR06952.1| glutelin type-B [Oryza sativa Japonica Group] >gi|47497729|dbj|BAD19794.1|  glutelin type-B [Oryza sativa Japonica Group] >gi|113535965|dbj|BAF08348.1| Os02g0248800 [Oryza sativa Japonica Group]  >gi|215768942|dbj|BAH01171.1| unnamed protein product [Oryza sativa Japonica Group] >gi|284431772|gb|ADB84627.1|  glutelin [Oryza sativa Japonica Group] MTISVFSRFSIYFCVLLLCNGSMAQLFDPATNQWQTHRQGSFRECRFERLQAFEPLQNVRSEAGVTEYFDETNELFQCTGTFVIRRVIQPQGLL IPRYANTPGMVYIIQGRGSMGLTFPGCPATYQQQSQQFLFQGESQSQKFIDEHQKIHQFRQGDIVVLPTGVAHWFYNDGDTPVVALYVYDI NNSANQLEPRHREFLLAGKNNRVQQVYGRSIQQHSGQNIFNGFSVEPLSEALN1NTVTTKRLQSQNDQRGEIIHVKNGLQLLKPTLTQRQEQE QAQYQEVQYSEKPQTSSRWNGLEENLCTIKTRLNIENPSRADSYDPRAGRITSLDSQKFPILNIIQMSATRVNLYQNAILTPFWNVNAHSLMYV IRGRARVQVVSNFGKTVFDGVLRPEQLLIIPQNYVVLKKAQHEGCQYIAINTNANAFVSHLAGVDSVFHALPVDVIANAYCISREEARRLKNNR GDEYGPFPPRLQQQIYPEFSNESKGETSE [SEQ ID NO: 527] >gi|428674402|gb|AFZ41188.1| glutelin, partial [Oryza sativa Japonica Group] LLCHGSMAQIFSLGINPWQNPRQGGSRECRFDRLQAFEPLRKVRHEAGVTEYFDEKNEQFQCTGTLVIRRIIEPQGLLLPRYSNTPGLVYIIQGT GVLGLTFPGCPATYQKQFRHFGLEGGSQRQGKKLRDENQKIHQFRQGDVVALPSGIPHWFYNEGDTPVVALFVFDVNNNANQLEPRQKEFL LAGNNIEQQVSNPSINKHSGQNIFNGFNTKLLSEALGVNIEVTRRLQSQNDRRGDIIRVKNGLRLIKPTITQQQEQTQDQYQQIQYHREQRSTS KYNGLDENFCAIRARLNIENPNHADTYNPRAGRITNLNSQKFSILNLVQMSATRVNLYQNAILSPFWNINAHSLVYTIQGRARVQVVSNHGKA VFNGVLRPGQLLIIPQNYVVMKKAELEGFQFIAFKTNPNAMVNHIAGKNSVLRAMPVDVIANAYRISRQEARSLKNNRGEEIGAFTPRYQQQ KIHQEYSNPNESETQ [SEQ ID NO: 528] >gi|226510|prf| 11515394A seed storage globulin MATTRFPSLLFYSCIFLLCNGSMAQLFGQSFTPWQSSRQGGLRGCRFDRLQAFEPLRQVRSQAGITEYFDEQNEQFRCAGVSVIRRVIEPQGLL LPQYHNAPGLVYILQGRGFTGLTFPGCPATFQQQFQPFDQARFAQGQSKSQNLKDEHQRVHHIKQGDVVALPAGIVHWCYNDGDAPIVAV YVFDVNNNANQLEPRQKEFLLAGNNKREQQFGQNIFSGFSVQLLSEALGISQQAAQKIQSQNDQRGEIIRVSQGLQFLKPFVSQQGPVEHQA YQPIQSQQEQSTQYQVGQSPQYQEGQSTQYQSGQSWDQSFNGLEENFCSLEARQNIENPKRADTYNPRAGRITHLNSKNFPTLNLVQMSA TRVNLYQNAILSPYWNINAHSVMHMIQGRARVQVVNNHGQTVFNDILRRGQLLIIPQHYVVLKKAEREGCQYISFKTTPNSMVSYIAGKTSIL RALPVDVLANAYRISRQESQNLKNNRGEEFGAFTPKFAQTGSQSYQDEGESSSTEKASE [SEQ ID NO: 529] P07730 (Rice) >gi|225959|prf| 11404367A glutelin MASTNRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDRLQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGL LLPHYTNGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAGLTESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDCEVPVVAIYV TDINNGANQLDPRQRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQLQCQNDQKGEIVRVERGLSLLQPYASLQEQ EQGQMQSREHYQEGGYQQSQYGSGCPNGLDETFCVNKVRQNIDNPNRADTYNPRAGRVTNLSQNFPILNLVQMSAVKVNLYQNTDTWIS MGQEENALLSPFWNINAHSIVYITQGRAQVQVLRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPTDVLANAYRIS REEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [SEQ ID NO: 530] >gi|573943558|ref|XP_006654150.1| PREDICTED: glutelin type-A 3-like [Oryza brachyantha] MKSSIVFSTICLVLLCHGSLAQLLSQSTSQWQSSRRGSPRQCRFDQLQAFEPIRTVRSQAGVTEFYDVSNELFQCTGVSVVRRVIEPRGLLLPHY SNGATLVYIIQGRGITGPTFPGCPETYQQQFQQSGEAQPFEGQSHKFRDEHQKIHRFRQGDVVALPAGVAHWCYNDGEVPIVAIYVTDIYNS ANQLDPRHRDFFLAGNNKVAQQLYRSEARENSKNIFGGFSVELLSEALGISRGVARQLQCQNDQRGEIVRVEHGLALLQPYASVQEQQQEQV QSRDYEQTQYQQKQPQGSCSNGLDETFCTMRLRQNIDNPNLADTYNPKAGRITYLNGQKFPILNLVQMSAVKVNLYQNAVLSPFWNINAHS VVYITQGRARVQVVNNNGKTVFDGELRQGQLLIIPQHHVVLKKAQREGCSYIALKTNPNSIVSHIAGKNSIFRALPGDVVTNAYRISREEAKRIK HNRGDESGVFAPSHAYRSYQDMSVAA [SEQ ID NO: 531] >gi|721641733|ref|XP_010231907.1| PREDICTED: 12S seed storage globulin 1-like  [Brachypodium distachyon] MAHTSFSSFLSYFCLFLLFHGSMAQVLGQVSTWQSSRQGGSRDCSFDRLQAIEPVTQVRSQAGLTEYFDEQNEQFRCAGVFVIRRVIEPRGLL LPRYHNTPGLVYILQGNGFVGLTFPGCPETFREQFQQFRQTQSTLGQSQCQSQKLGDVHQRVHQFTQGDVVALPTGVAHWIYNGGDAPVV IVYVFDVNNNANQLEPRQKEFLLGGNYNGVLQYGQNIFSGFNAQLLSQAFGINEQTSQRIQNQNDGRGDIIRVDNGLQFLKPVVTQQQPEQ PFMPIQHQTGQSSRNGLEENFCSLEPRQNIEDPNRADTYNPRAGSITRLNGQNFPILNLVQMSATRVNLQKNAILSPFWNINAHSVVYVIQG HALVQVVNNQGHNVFNGLLHRGQLLIIPQNYVVLKKAESEGYQYIAFKTNANSMVSHIAGKNSILRALPVDVIANAYRISRQEAQNLKNNRGE ETGVLTPNFSQSTCQSYQTEDVQSLRPMSHWSE [SEQ ID NO: 532] >gi|169244463|gb|ACA50505.1| seed allergenic protein RAG2 [Oryza sativa Japonica Group] MASNKVVFSALLLIIVSVLAATATMADHHKDQVVYSLGERCQPGMGYPMYSLPRCRAVVKRQCVGHGAPGGAVIDEQLRQDCCRQLAAVID DSWCRCSALNHMVGGIYRELGATDVGHPMAXVFPGCRRGIDLERAAASLPAFCNVIDIPNGTGGVCYWLGYPRTPRTGH [SEQ ID NO: 533] >gi|5777592|emb|CAA44001.1| low molecular weight globulin [Oryza sativa] MASNKVVFSALLLIIVSVLRRDGTMADHHKDQVVYSLGERCQPGMGYPMYSLPRCRAVVKRQCVGHGAPGAVDEQLRQDCCRQLAAVDD SWCRCSALNHMVGGIYRELGATDVGHPMAEVFPGCRRGDLERAAASLPAFCNVDIPNGTGGVCYWLGYPRTPRTGH [SEQ ID NO: 534] >gi|115471175|ref|NP_001059186.1| Os07g0214600 [Oryza sativa Japonica Group]  >gi|23616954|dbj|BAC20657.1| allergen RA16 [Oryza sativa Japonica Group] >gi|113610722|dbj|BAF21100.1|  Os07g0214600 [Oryza sativa Japonica Group] >gi|125557687|gb|EAZ03223.1| hypothetical protein Osl_25372 [Oryza sativa Indica Group] MASNKVVISALLVVVVSVLAATTTMADHHQEQVVYTPGQLCQPGIGYPTYPLPRCRAFVKRQCVAPGTVDEQVRRGCCRQLAAIDSSWCRC DALNHMLRI1YRESGAADAGHPMAEVFRGCRRGDIERAAASLPAFCNVDIPNGVGGVCYWLPGTGY [SEQ ID NO: 535] Q0DEV5 (Rice) >gi|83375868|gb|ABC17777.1| waxy [Oryza rufipogon] MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFVDHPSFLEKVWGKTGEKI YGPDTGVDYKDNQMRFSLLCQAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAFEDYP ELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYITAKYD ATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKFNAPLA HLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKVVGTPAYEEMV RNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAPLAKENVAAP [SEQ ID NO: 536] >gi|297614332|gb|AD148504.1| glycogen synthetase [Oryza officinalis] MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDASSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRHDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKI YGPDTGVDYKDNQMRFSLLCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLPSYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAF EDYPELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILESDRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYIA AKYDATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQENVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKF NAPLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVQKVATTLKRAIKIVGTPAY NEMVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGVEGEEIAPLAKENVAAP [SEQ ID NO: 537] >gi|389620054|gb|AFK93486.1| granule-bound starch synthase [Hordeum vulgare subsp. vulgare] MAALATSQLATSGTVLGVTDRFRRPGFQGLRPRNPADAALGMRTIGASAAPKQSRKAHRGSRRCLSVVVRATGSGMNLVFVGAEMAPWS KTGGLGDVLGGLPPAMAANGHRVMVVSPRYDQYKDAWDTSVISEIKVADEYERVRFFHCYKRGVDRVFIDHPWFLEKVRGKTKEKIYGPDA GTDYEDNQQRFSLLCQAALEAPRILNLNNNPYFSGPYGEDVVFVCNDWHTGLLACYLKSNYQSNGIYRTAKVAFCIHNISYQGRFSFDDFAQL NLPDRFKSSFDFIDGYDKPVEGRKINWMKAGILQADKVLTVSPYYAEELISDEARGCELDNIMRLTGITGIVNGMDVSEWDPTKDKFLAVNYDI TTALEAKALNKEALQAEVGLPVDRKVPLVAFIGRLEEQKGPDVMIAAIPEILKEEDVQIILLGTGKKKFEKLLKSMEEKFPGKVRAVVRFNAPLAH QMMAGADLLAVTSRFEPCGLIQLQGMRYGTPCVCASTGGLVDTIVEGKTGFHMGRLSVDCNVVEPADVKKVATTLKRAVKVVGTPAYQEM VKNCMIQDLSWKGPAKNWEDVLLELGVEGSEPGIVGEEIAPLAMENVAAP [SEQ ID NO: 538] P14323 (Rice) >gi|573918992|ref|XP_006647120.1| PREDICTED: glutelin type-B 2-like [Oryza brachyantha] MATTVFSRFSTYFCVLLLCHGSMAQLFNPSTNPWHNPRQGSSRECRFDRLQPFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLL VPRYTNAPGLVYIIQGRGSIGLTFPGCPATYQQQFQQFLPQEQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNDGDAPVVAVYVYDV KNSANQLEPRQREFLLGGNNMRAQQVYGSSAEQHSRQNIFSGFGVEILSEALGISTVTTKRLQSQNDQRGEIIHVKNGLQFLKPTLTQQQEQA QAQYQEVQYSEQQQTSSRWNGLDENFCTIKARMNIENTSRADTYNPRAGRTTSLNSQKFPILNLVQMSATRVNLYQNAILSTFWNVNAHSL VYTIQGRARVQVVSNFGKTVFDGELRPGQLLIIPQHYVVLKKAQREGFRYIAIKTNANAFVSQLVGKNSVFRSLPVDVIANVYRISREQARSLKN NRGEEHGAFAPRSQQQSYPGFSNQSESETSE [SEQ ID NO: 539] >gi|573919041|ref|XP_006647142.1| PREDICTED: glutelin type-B 4-like [Oryza brachyantha] MATTTFSRFSIYFCVLLLCHGSMAQLFSPTLNPWHSSRRGGSRDCRFDRLQAFEPLRRVRSEAGVTEYFDERNEQFQCTGTFVIRRVIEPQGLL VPRYTNTPGVVYIMQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNEGDTPVVALYVFD INNSANQLEPRQKDFLLAGNNNREQQVYGRSIEKHSGQN1FSGFNHELLSEALGISTLAAKRLQGQNDHRGEIIRVRNGLQLLKPTFTQQQEQ AQSQYQVQYSEKQQESTRCNGLDENFCTINARLNIENPSRADTYNPRAGRITHLNNQKFPILNLVQMSATRVNLYQNAILSPYWNVNAHSLV YMVQGHARVQVVSNLGKTVFNSVLRPGQLLIIPQHYVVLKKAEREGCQYIAFKTNANSIVSQLAGKNSILRAMPVDVVANAYRISREQARDLK NNRGEELGAFTPKFEQQSYPGLSNESESEASE [SEQ ID NO: 540] >gi|109894635|gb|ABG47337.1| glutelin precursor [Zizania latifolia] MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFDRLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRG LLLPQYTNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFKDEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVA IYVIDINNAANQLDPRQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQKQEQPRERYQVTQHQQSQYGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILNLIQMSAVKVNLYQNALLSP FWNINSHSVVYVTQGCARVQVVNNNGKTVFNGELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFRALPTDVLANAY RISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID NO: 541] P29835 (Rice) >gi|226508602|ref|NP_001152635.1| globulin precursor [Zea mays] >gi|195658363|gb|ACG48649.1|  globulin precursor [Zea mays] MAKIAAAAAAAAALCFAALVAVAVCQGEVERQRLRDLQCWQEVQESPLDACRQVLDRQLTGGGVGGPFRWGTGLRMRCCQQLQDVSRE CRCAAIRSMVRGYEEAMPPLEKGWWPWGRQQQPPPQGGGGGQGGYYYPCSRAGEGYQTQMYPPCRPGTTGPRIGRVRLTKAREYAAGL PMMCRLSEPQECSIFSGGDQY [SEQ ID NO: 542] >gi|242090997|ref|XP_002441331.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghum bicolor] >gi|241946616|gb|EES19761.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghum bicolor] MAKIAAVAATAALCLAALVAVAVGQGVVERQRLKDLQCWQEVQENPLGACRQVLDRQLTGGMRYGIGPFRWGTGLRMRCCQQLQDVSR ECRCAAIRSMVRGYEETMPPLEKGWWGQQPQPGYDYPCSQAGEGYGYGESGQQQMYPPCRPGTGQKIARVKLTKARQYAAGMPMMCR LSEPQECSVFSGGDQYY [SEQ ID NO: 543] >gi|514748428|ref|XP_004961615.1| PREDICTED: 19 kDa globulin-like [Setaria italica] MAKFVVAAATAALCLAALVAMAAGQSGFERQRLRDLRCQREVEENPLWACRQVLDRQLTGGMRYGVGPFRWGTGLRMRCCQQLQDVS RECRCSAVRRMVRGYEEAMPPLEEGPYGYGGEQGEGYYGGGEGGEGYLPFPPRRIGRVRLTKARQYAAGLPMMCRLEPQECSVFSGDQYK [SEQ ID NO: 544] P0C1U8 (Bacterial) GLUC (Staphylococcus aureus) >gi|446599182|ref|WP_000676528.1| glutamyl endopeptidase [Staphylococcus aureus]  >gi|253729369|gb|EES98098.1| trypsin [Staphylococcus aureus subsp. aureus TCH130] >gi|341844549|gb|EGS85761.1|  glutamyl endopeptidase [Staphylococcus aureus subsp. aureus 21259] >gi|537390486|gb|AGU61109.1|  Glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus CN1] >gi|564714561|gb|ETD14665.1|  glutamyl endopeptidase [Staphylococcus aureus subsp. aureus KPL1845] >gi|577466329|gb|EUG79766.1|  glutamyl endopeptidase [Staphylococcus aureus M0139] >gi|580560623|gb|EVF84961.1| glutamyl endopeptidase [Staphylococcus aureus CoA56020] >gi|580687002|gb|EVH10169.1| glutamyl endopeptidase [Staphylococcus aureus UCIM6080] >gi|751815683|gb|KIN24957.1| glutamyl endopeptidase [Staphylococcus aureus MRSA_CVM43477] >gi|781884797|dbj|BAR08486.1| glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus] >gi|781887762|dbj|BAR11210.1| glutamyl endopeptidase precursor [Staphylococcus aureus subsp. aureus] MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQSQSSKQQTPKIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYi QVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTAEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMS NNAETQVNQNITVTGYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNEFNGAVFINENVRNFLKQ NIEDIHFANDDQPNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID NO: 545]